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SMALL SCALE SERVICE RELATED PROJECT
User Satisfaction with a Psychoeducation Group for Patients with 
Schizophrenia/Psychosis and their Carers
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Mooney P., Stallard A., & Alexander F. (2006). User satisfaction with a Psychoeducation 
Group for People with a Diagnosis of Schizophrenia/ Psychosis and their Carers. Clinical 
Psychology, 164, 11-16.
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the degree of Doctor of Clinical Psychology
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Summary
This study assessed user satisfaction with a psychoeducation group programme for patients 
with schizophrenia/psychosis and their carers. Results were found to be positive. 
Recommendations for future changes to the group and the audit process are made.
Introduction
UK clinical guidelines recommend that patients with a diagnosis of 
schizophrenia/psychosis and their carers should be provided with information/education 
regarding their problem (e.g. SIGN, 1998; NICE, 2002). Notably, the Clinical Standards 
Board for Scotland (2001) advise that “giving users and carers information about the 
illness and available services/treatments available improves understanding, helps maintain 
vital relationships and improves outcomes for users and carers in the longer term”.
Theoretical accounts of schizophrenia and empirical evidence support these 
recommendations. The vulnerability stress model of schizophrenia proposes that a range 
of biological, psychological and psychosocial factors interact and determine the course and 
outcome (Nuechterlein et al, 1994). The principle of this formulation, that psychological 
and social stressors and mediators can influence the course of schizophrenia, lends impetus 
to psychosocial management strategies to modify these factors and hence bring about 
positive change in the course of the disorder. A recent review of research involving both 
clients and carers concluded that “psychoeducational approaches are useful as part of the 
treatment programme for people with Schizophrenia and related illnesses” (Pekkala and 
Merinder, 2001).
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The nature and method of delivery of these approaches can vary. Some programmes go 
beyond the provision of information and take an educational approach to skills training or 
problem solving (Hogarty et al, 1991). Birchwood et al (1992) found that simple 
information giving is less effective than interactive sessions. In addition, the importance of 
the family environment has long been recognised, with supportive familial relationships 
been shown to enhance treatment compliance (Oehl et al, 2000) and to reduce the 
likelihood of relapse (Bebbington and Kuipers, 1994). A recent review by Pharoah et al 
(2004) found that family interventions may decrease the frequency of relapse, encourage 
compliance of medication and improve general social impairment. Furthermore, family 
work to address problems may not be effective if the patient is not included (Bruchremer et 
al, 1995). Carrying out such work in a group setting has been shown to be advantageous 
(Birchwood et al, 1992). Group work can be cost effective and can offer a source of social 
support for members.
There is evidence that negative experiences of contact with psychiatric services can impair 
engagement (Tarrier and Barrowclough, 1988). This highlights the importance that any 
psychoeducation programme is delivered clearly, is understandable and paced 
appropriately for all recipients. This is particularly important for people with 
schizophrenia/psychosis, given the cognitive impairments such as information processing 
deficits often evident in this population (Silverstein et al, 1998). Thus, clinical standards 
for Schizophrenia state that “information should be given in a way that the person can 
understand to the best of their ability at the time” (Clinical Standards Board for Scotland, 
2002).
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The review of clinical practice through audit is a well established means of promoting the 
quality of clinical care by identifying shortfalls in performance against standards and best 
practice. However, although outcomes in schizophrenia/psychosis such as relapse rates are 
commonly measured, patients’ and carers’ satisfaction with services provided are often not 
carried out in any formal way (Scottish Intercollegiate Guidelines Network, 1998). 
Encouraging patients/carers to make comments, suggestions and complaints about services 
allows the organisation to gain a patient’s perspective which should inform the review and 
development of services, practices and procedures. Thus, feedback is paramount to 
ensuring quality and improving performance. As such, the Clinical Standards Board for 
Scotland (2002) regards it essential that user and carer satisfaction are audited.
This study aims to solicit feedback from users of a psychoeducation group for people with 
schizophrenia/psychosis and their carers. More specifically, this study aims:
1. To investigate whether the practical arrangements of the group were acceptable
2. To assess helpfulness of individual sessions
3. To investigate what participants found most or least beneficial about attending the 
group
4. To investigate whether participants have made any positive lifestyle changes as a 
result of attending the group
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Method
Population
Adult outpatients with a diagnosis of schizophrenia or psychosis and their carers attending 
a psychosocial education programme run by a Community Mental Health Team in 
Inverclyde were invited to participate in the study. A total of 30 participants attended this 
programme in 4 separate groups of 6 to 8 people. 16 group members agreed to take part in 
this research by completing the study questionnaire. No demographic details are available 
for participants.
Materials
A questionnaire was developed to investigate patient satisfaction (Appendix 1.2). This 
included items that can be categorised according to the themes identified in the aims of this 
study (see Figure 1 below). Response formats varied.
Readability of the questionnaire was assessed using the Flesch (1948) scoring procedure 
which yielded a score of 75.8 (reading level 5th grade), placing it above the ‘normal’ range 
of 60-70 (range 0-100). However, this was considered acceptable.
5
Figure 1. Categorisation of Questions
Whether the practical 
arrangements o f  the 
group were acceptable
Did you find it beneficial to attend the group together? 
Would it have been more useful to attend a group on 
your own?
Did you find the handouts useful?
Do you still refer to the handouts?
Would you be interested in attending a self-help group 
or a carers’ forum?
Was the time o f  the group suitable?
Was the location o f  the group suitable?
Y es/N o
Helpfulness o f  individual 
sessions
How helpful did you find each o f  the eight sessions? 
Session 1 -  Introduction, outline o f  sessions 
Session 2 -  What is schizophrenia?
Session 3 -  Symptoms o f  schizophrenia 
Session 4 -  Medication issues 
Session 5 -  Stress/relaxation 
Session 6 -  Problem solving 
Session 7 -  Relapse prevention 
Session 8 -  Ongoing topics/ evaluation
Very helpful/ 
Quite helpful/ 
Not helpfiil / 
N/A
What participants found 
most or least helpful 
about attending the group
What did you find most helpful about attending the 
group?
What did you find least helpful about attending the 
group?
N o choice 
-  free text
Whether participants 
have made any positive 
lifestyle changes since 
attending the group
Have you made any lifestyle changes since attending 
the group?
Indicate which:
Having a greater understanding o f  condition; feeling 
more able to control symptoms and manage relapse; 
feeling more able to discuss difficulties with family/ 
friends; feeling more able to discuss aspects o f  care 
with professionals; using relaxation techniques; using 
problem solving techniques; meeting other people in 
similar situations; improving relationships between 
person with diagnosis and carer attending group.
Y es/N o
Group
Groups consisted of eight weekly sessions each lasting approximately one and half-hours, 
including a break for refreshments. In order to be more convenient and accessible, 
sessions were held in the evening at 5.45pm at the offices of the Community Mental Health 
Team, which are centrally located by a shopping precinct. Groups were staffed primarily 
by Community Psychiatric Nurses, but other disciplines such as occupational therapists 
and clinical psychologists also had considerable input.
The group postulated clearly defined goals which are summarised below:
1. Integration of the psychotic experience
2. Acceptance of the vulnerability to further episodes
3. The importance of psychotropic medication for symptom control
4. The significance of stressful life events as triggers for reoccurrence of symptoms
5. Distinguishing personality from disorder
6. Increasing participants’ social support network.
Groups were run in an informal manner, encouraging all attending to participate and help 
shape the content of discussions. Sessions followed a format similar to that used by 
Atkinson et al (1996) and included an information session (short presentation and 
discussion) followed by a problem solving exercise. Each session was allocated to a 
specific topic. The first three focussed on education regarding the nature of schizophrenia 
(aetiology, symptoms and prognosis), as well as treatment and management. Subsequent 
sessions incorporated work on stress management, problem solving and relapse 
identification/ prevention drawing on the work of authors such as Falloon (1986) and 
Goldstein (1994). A final session was included to cover any areas of continuing concern to 
participants. Handouts were provided at each meeting which included all topics covered.
Procedure
Participants were asked to complete the questionnaire at the end of the eight week 
programme. The researcher did not obtain written informed consent as this information 
was routinely collected as part of clinical practice. However, participants were informed by
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staff that involvement was voluntary, anonymous and that results would be used to 
improve future groups. They were also notified that the information obtained may be 
disseminated through academic channels but that there would be no identifiers in this 
work.
Data was anonomised at source, as participants were not required to complete their name 
on the questionnaire. The results were then forwarded on to the researcher by staff 
facilitating the group. The researcher was blind to the identity of the participants of the 
group. The data was collected from several groups running between March 2002 and 
January 2004. Analysis was carried out between February 2004 and July 2004.
Results
Results were analysed descriptively according to the aims stated.
Aim 1: To investigate whether the practical arrangements of the group were
acceptable
Responses were converted into frequencies and are presented in Table 1.
Table  1. Practical A rra n g em en ts  o f  G roup
Question No Yes Don't know
Beneficial to attend group 
together 1 13 1
M ore useful to attend a group 
alone 9 2 3
Handouts useful 1 13 0
Still refer to handouts 4 10 0
Interested in self-help or 
carers' forum 2 13 0
Time suitable 2 14 0
Location suitable 0 14 0
14 participants reported the time (87.5 %, n=16) and location (100%, n=14) o f  the group 
suitable. 13 people (86.7%, n=15) felt it useful to attend the group together. 13 respondents 
(86.7%, n=15) found the handouts useful and 10 (71.4%, n=14) acknowledged that they 
still referred to them. 13 group members (86.7%, n=15) expressed an interest in attending a 
future self-help group or carers forum.
Aim 2: To assess helpfulness of individual sessions
Once again, the results were converted into a frequency chart according to the feedback 
ratings o f  each individual session. The results are presented in Table 2.
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Table  2. Ratings o f  session
Session No. Very Helpful Quite Helpful Not Helpful N/A
1 7 6 0 3
2 10 5 0 0
3 10 5 0 0
4 8 6 0 0
5 10 4 1 0
6 6 7 0 2
7 8 7 0 0
8 5 7 0 0
The modal response for all sessions, with the exception o f  sessions 6 and 8, was ‘very 
helpful’. Indeed, with regards to sessions 2, 3 and 5, 10 respondents (66.7%, n=15) found 
these sessions very helpful. Only one person reported finding any o f  the sessions unhelpful 
(session 5).
Aim 3: To investigate what participants found most or least beneficial about 
attending the group
The qualitative data was analysed according an idiographic case study approach, drawing 
on principals o f  Interpretative Phenomenological Analysis (Smith, 1996). Inter rater 
reliability for this data was calculated and found to be satisfactory. Both raters agreed in 
79.2% o f  cases in the first instance. After reanalysing the data by means o f  collapsing 
some categories, agreement reached 89.6%. Some o f  the com m on themes found are 
reported here.
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Most Beneficial
The most common theme emerging in response to this question was that of social support. 
Half of those who gave an answer indicated that they found the social support received 
from others in the group was one of the most helpful components of the group. Comments 
included “talking with and meeting others in the same position” and the “group sharing 
how they coped in their situation with the illness”. Another common theme found to be 
helpful was the education component, with session topics commonly being raised as the 
most helpful aspect of the programme. A broad range of topics were highlighted as being 
useful, for example, “problem solving” and “symptoms of schizophrenia”.
Least Beneficial
The most predominant response to this question was “nothing”, with replies including “(I) 
thought it was all helpful” and “there were helpful facts at all the meetings”.
Aim 4: To investigate whether participants have made any positive lifestyle changes 
as a result of attending the group
11 participants (73.3 %, n=15) reported having made positive lifestyle changes as a result 
of attending the group. The frequencies of each change made are demonstrated graphically 
in Figure 2.
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Figure 2. Positive Changes Made Since Attending Group
Changes
□  G reater understand ing of 
condition
■  M ore able to con tro l sym ptom s 
and m anage re lapse
□  M ore able to d iscuss difficu lties
S  M ore able to d iscuss care with 
p ro fesssiona ls
□  Using re laxation techn iques
□  Using problem  solving 
techniques
□  M eeting o ther people in sim ilar 
s itua tions
□  Im proved re la tionsh ip  between 
pa tie t and carer
The largest proportion, 14 (93.3%, n=15), reported one o f  the positive lifestyle changes as 
having a greater understanding o f  the condition. 13 people (86.7%, n=15) reported an 
improved relationship between patient and carer and 12 (80%, n=15) identified meeting 
other people in similar situations. However, only 7 participants (46.7%, n=15) 
acknowledged feeling more able to discuss care with professionals. Fewer made changes 
by using skills taught in the group. 5 (33.3%, n=15) reported using relaxation techniques 
and 6 (40%, n=15) using problem solving techniques taught in the group.
Discussion
This study intended to solicit feedback with four specific aims.
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Aim 1: To investigate whether the practical arrangements of the group were 
acceptable
Analysis of results assessing the practical arrangements of the group found these to be 
acceptable. The majority of respondents endorsed the location and timing of sessions. Most 
preferred the opportunity to attend a group with both patients and carers. These results 
should be interpreted with caution as it could be argued that those who found these 
arrangements unsuitable are less likely to have attended the group. In addition, a large 
majority expressed an interest in attending a future self-help group or carers forum. As a 
result of this feedback, both carers and client support groups have been developed in this 
service.
Aim 2: To assess helpfulness of individual sessions
Overall, sessions were found to be helpful. The sessions found to be most helpful appear to 
be those discussing the aetiology and symptoms of schizophrenia and the session teaching 
stress management and relaxation.
Aim 3: To investigate what participants found most or least beneficial about 
attending the group
The social support received in these groups appeared to be the most often cited benefit of 
attending. This result is pleasing, given that individuals with psychosis or schizophrenia 
and their families often become socially isolated (Bengtsson et al, 2001) and that social 
support is predictive of quality of life and can serve as a protective factor against
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psychological distress (Ritsner et al, 2000). Session topics were also commonly cited as 
being the most beneficial thing about attending the group. Overall, it appears that little was 
found not to be beneficial to participants.
Aim 4: To investigate whether participants have made any positive lifestyle changes 
as a result of attending the group
The majority of participants reported having made positive lifestyle changes as a result of 
attending the group and many report having made multiple changes. The most common 
changes include improved relationships between patient and carer. This may have positive 
consequences, given the importance of the family environment on compliance and 
outcome (Oehl et al, 2000; Bebbington and Kuipers, 1994). A further change commonly 
reported was meeting others in the same situation. This potentially has far reaching 
implications when bearing in mind the role of social support in protecting against 
psychological distress.
Among the least common changes reported was implementing some of the techniques 
taught in the sessions, namely utilising problem solving and relaxation skills. This 
highlights a disparity between how helpful sessions on these topics were found to be and 
whether participants utilised the techniques after the group had ended. One explanation 
could be that perhaps the participants did not fully understand the methods or rationale for 
using these techniques and, as such, session content may require revision. This appears 
unlikely as it is anticipated that any misunderstanding in these areas would have been 
reflected in the ratings of these sessions. However, it must be borne in mind that 
participants may report sessions to be helpful in order to please staff even if they do not
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fully understand, remember or use the strategies taught. Thus, further investigation as to 
why this disparity exists may be merited. Perhaps ‘booster sessions’ carried out after the 
programme has ended would reinforce the usefulness of these techniques, refresh 
participants memories regarding the methods used and encourage individuals to engage in 
these activities in the future.
In addition, feeling more able to discuss aspects of care with health/ social care 
professionals was also less commonly reported. Although the group is multidisciplinary in 
nature, in reality it could be argued that it is primarily led by nursing and support staff. 
Perhaps involving staff from other disciplines and agencies more frequently may go some 
way to alleviating concerns and helping individuals feel more comfortable conversing with 
different professional groups.
Methodological Considerations
These results should be interpreted with the following caveats in mind. Not least is the fact 
that the numbers in this sample are small and, as such, conclusions or generalisations 
should be made tentatively. Furthermore, as questionnaires were anonomised at the point 
of completion, there is no way of ascertaining which respondents are patients or carers. 
Future work may wish to consider analysing data from patients and caregivers separately 
while continuing to ensure anonymity. This would identify if both patients and carers 
opinions’ were equally represented.
In addition, feedback was solicited on the last of the eight weekly sessions. Given the 
cognitive difficulties commonly experienced by people with schizophrenia (Silverstein et
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al, 1998) already discussed, this may affect the accuracy of feedback and increase the 
anxieties of those providing feedback. Therefore, a further refinement could be to solicit 
feedback on individual sessions at the end of that session. It may also be beneficial to 
check that group members have understood and recalled information learned in sessions to 
ensure that it has been remembered before assessing whether it has had the desired impact.
More specifically, the question regarding positive lifestyle changes may have been 
confusing to some respondents. This question asked respondents to indicate yes or no to 
whether they had made any positive lifestyle changes since attending the group. If 
participants responded yes, they were prompted to indicate what changes they made from a 
selection of items. However, some of the options offered in this section were similar to 
topics discussed in sessions and may have been misinterpreted as asking participants what 
they enjoyed about the group. As a result, on three occasions, participants responded no to 
“Have you made any lifestyle changes since attending the group?”, but subsequently went 
on to select some of the choices of lifestyle changes. Rephrasing this question may 
overcome some of these difficulties.
Conclusion
Changes may be made in the audit process to make it more robust. However, the sample 
studied appears to be satisfied with the practicalities, content and social support offered by 
the group. Thus, not only is there a strong evidence base for this type of work but it is also 
found to be useful and acceptable to participants. Future groups may wish to draw on 
features of the current one, remaining cognisant of the recommendations for change 
suggested.
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Chapter 2
SYSTEMATIC LITERATURE REVIEW
A Systematic Review of the Effectiveness of Non-pharmacological 
Interventions for Sleep Maintenance Insomnia
Systematic Literature Review submitted in partial fulfilment of the requirement for the 
degree of Doctor of Clinical Psychology
Prepared in accordance with the guidelines for Clinical Psychology Review (Appendix 
2 . 1).
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ABSTRACT
Non pharmacological interventions are fairly well established in the treatment of initial 
insomnia. However, the effectiveness of non pharmacological treatments for sleep 
maintenance insomnia is not clear. This review assessed the effectiveness of non- 
pharmacological interventions for sleep maintenance insomnia in adult and older adult 
populations ( > 1 8  years). Ten articles that examined the use of non pharmacological 
interventions (two bright light therapy and eight psychological interventions) were 
identified following a systematic search of electronic databases, and hand searching of 
relevant journal titles. Generally, the quality of the studies was variable. There was little 
evidence for the effectiveness of bright light therapy. In contrast, there was evidence to 
suggest that psychological interventions are effective in treating sleep maintenance 
insomnia. It was not, however, possible to delineate which components are most effective.
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1. INTRODUCTION
1.1 Insomnia
Primary insomnia (PI) is a heterogeneous disorder and debilitating sleep problem 
(Association of Sleep Disorders Centers, 1979; Coleman et al, 1982). PI is defined as 
difficulty initiating or maintaining sleep, or non-restorative sleep, which is associated with 
significant distress and daytime impairment and not due to other medical, psychiatric or 
sleep disorders (APA, 1994). In other nosologies, it is referred to as ‘psychophysiologic 
insomnia’ (ASDA, 1997). Prevalence estimates vary, but approximately 10% to 15% of the 
adult population (Mellinger et al, 1985: Ford & Kamerow, 1989) experience PI on a 
chronic basis. This rate increases to between 12 and 40% in people over age 65 
(Montgomery & Dennis, 2004).
Chronic PI can have several adverse affects. These may be psychosocial, occupational, 
health and economic in nature (Morin, 1993). For example, PI patients experience more 
psychological distress compared to healthy controls, show impairments to daytime 
functioning, make use of health care services more often than good sleepers, and show 
increased absences from work (Mellinger et al, 1985; Ford & Kamerow, 1989; Gallup, 
1991; Kales etal, 1984).
Complaints of PI are typically divided into problems of falling asleep (sleep-onset or initial 
insomnia), problems staying asleep (sleep-maintenance insomnia) and problems 
awakening too early in the morning (terminal insomnia; Morin, 1993). There is now a 
reasonably large insomnia treatment literature, which demonstrates non-pharmacological
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interventions as fairly well established in the treatment of initial insomnia (Harvey, 2005; 
Smith et al, 2002; Morin et al, 1999; Murtagh & Greenwood, 1995). The past ten years 
has also witnessed an expanding experimental cognitive literature, concerned with 
cognitive factors associated with sleep onset difficulties (Espie, 2002; Broomfield et al, 
2005). However, despite this body of work, there has been a relative lack of research 
attention focused specifically on sleep-maintenance difficulties. This is surprising, 
particularly given that maintenance problems are a more common complaint among adults 
than sleep-onset insomnia, especially those of middle and older age (Karacan et al, 1983; 
Bixler et al, 1979).
1.2 Pharmacology
The most common treatments for PI are pharmacological (Morin et al, 1999; Walsh & 
Schweitzer, 1999; Kupfer & Reynolds, 1997). Benzodiazepines, sedative anti depressants 
and ‘Z drugs’ are the most commonly prescribed (National Institute of Clinical Excellence, 
2004). In 1999, the NHS in England spent £33.6 million on anxiolitics and hypnotics 
(Department of Health, 1999). Furthermore, a disproportionate number of older adults with 
PI receive sedative hypnotic medications as their primary or sole treatment (Dement et al, 
1982). However, whilst hypnotic medications may be useful in the short-term management 
of sleep maintenance difficulties, they provide only symptomatic relief, and do not address 
underlying mechanisms that maintain these difficulties. Consequently, patients who use 
hypnotics on a long-term basis often experience drug tolerance, dependence, “daytime 
hangover” effects, rebound insomnia and a gradual return of their sleep problems (Hauri, 
1982; Johnson & Chernik, 1982; Kales et al, 1974). Iatrogenic effects may be particularly 
problematic among older individuals who are at increased risk for toxic drug interactions
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and serious falls as a result of over sedation (Dement et al, 1982; Ray et al, 1987). Clearly, 
therefore, safe alternative therapies which are effective in the long term are required to 
treat younger and older adults with sleep maintenance difficulties.
1.3 Non-pharmacological Interventions
Non-pharmacological interventions are now well established in the treatment of PI (Espie, 
2002). Various cognitive and behavioural therapies have been developed for the treatment 
of sleep onset difficulties and PI in general (e.g. Morin & Espie, 2003; Espie et al, 2001; 
Edinger & Samson, 2003). Cognitive and behavioural therapy (CBT) treatments include a 
range of interventions, ranging from educational packages to behavioural techniques to 
cognitive interventions. Most contain more than one component. Specific treatments will 
be discussed later in this paper. Suffice to say, these approaches target the mechanisms 
presumed to maintain sleep difficulties e.g. oversleeping, poor stimulus control and ‘trying 
hard’ to get to sleep. They also aim to improve sleeping habits and challenge thoughts, 
attitudes and beliefs about sleep to varying degrees.
Non-psychological treatments such as bright light therapy (BLT) aim to re-establish 
appropriate phase relationship between the temperature rhythm and timing of sleep, 
thereby improving maintenance of sleep.
Practice guidelines established by American Academy of Sleep Medicine (Morin et al, 
1999) routinely recommend the use of certain non-pharmacological approaches in this 
population. Cognitive Behaviour Therapy (CBT) is the most effective psychological 
intervention for PI. Meta analyses report moderate to large effect sizes (Morin et al, 1999; 
Murtagh & Greenwood, 1995), with 70% to 80% of patients benefiting (Morin et al, 1999).
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These effects hold for older adults, although not on all outcomes (Montgomery & Dennis, 
2004). Although CBT based interventions show slower effects than pharmacology, they 
produce much more durable improvements (Morin et al, 1999; Hauri, 1997; McClusky et 
al, 1991).
However, whilst current evidence would suggest CBT is the treatment of choice for PI in 
general, the effectiveness of these treatments specifically for sleep maintenance problems, 
is less clear. Whereas several treatment reviews and guidelines have been published in the 
area of PI (e.g. Edinger & Meams, 2005; Murtagh & Greenwood, 1995; Montgomery & 
Dennis, 2004; Morin et al, 1999), not all of these include the differing insomnia’s (initial 
versus maintenance versus terminal). Of those that do, many either do not carefully 
delineate or report sleep maintenance effects from sleep onset effects, only assess the 
efficacy of one treatment (e.g. CBT; Edinger & Meams, 2005) or only consider one 
specific population (e.g. older adults; Montgomery & Dennis, 2004). Others do not provide 
a comprehensive review comparing effect sizes of the relative interventions, or have been 
rendered ‘out of date’ by a burgeoning literature since their publication (Morin et al, 1994; 
Murtagh & Greenwood, 1995). There is therefore a clear need to systematically review the 
effectiveness of non-pharmacological interventions specifically for sleep maintenance 
insomnia using carefully delineated maintenance insomnia patient populations. This 
should usefully inform clinicians of the best evidence based practice in this field.
2. OBJECTIVE
The objective of the present review, therefore, was to assess the effectiveness of non- 
pharmacological interventions for sleep maintenance insomnia in adult and older adult
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populations (>18 years). Specifically, the review examined reductions in wake time after 
sleep onset (WASO) and number of nocturnal awakenings (NOA). As interventions aimed 
at reducing sleep maintenance problems may also have an effect on other sleep parameters, 
total sleep time (TST), sleep efficiency (SE) and sleep onset latency (SOL) were also 
recorded.
3. METHODS
3.1 Search Strategy
PsychlNFO, MEDLINE, EMBASE, and The Cochrane Library of Systematic Reviews 
were searched from 1980 until Week One January 2006, using the terms insomnia, sleep 
maintenance, intervention, and treatment. In addition, Behavioural Sleep Medicine, Sleep, 
Journal of Sleep Research, Sleep Medicine Reviews and Sleep Medicine were hand 
searched to identify trials not electronically indexed. All were searched from 1980 or their 
first issue (if after 1980). Citation lists from other relevant studies were also examined to 
identify any relevant studies not cited elsewhere.
3.2 Types o f Studies
• Inclusion criteria: Randomised controlled trials, controlled trials, controlled single­
case series designs, uncontrolled case-series and uncontrolled single-case designs 
where the main purpose of the study was to evaluate the effectiveness non- 
pharmacological interventions for sleep maintenance insomnia. All studies assessed
changes in sleep according to recognised objective (e.g. polysomnography; PSG) and/ 
or subjective (e.g. sleep diaries) criteria.
• Exclusion criteria: Studies in which insomnia was secondary to any other medical or 
psychiatric conditions. Studies which also included sleep onset difficulties. Studies 
which primarily aimed to assess variables other than sleep (e.g. the proposed effective 
mechanisms of interventions).
3.3 Types o f Participants
• Inclusion criteria: 18 years and above; diagnosis of sleep maintenance insomnia.
• Exclusion criteria: <18 years old; organic condition; mental health problems; 
disordered breathing; other health problem which could influence sleep (e.g. pain, 
cardiac problems).
3.4 Results o f Literature Search
Searching the electronic databases using the terms above (with a restriction of adult human 
only studies) initially retrieved 152 results. Removing duplicate studies reduced this 
number to 91. Further removing those which did not specifically relate exclusively to sleep 
maintenance insomnia, non-pharmacological treatment, where studies involved a 
pharmacological treatment arm, or where it was explicitly stated that sleeping difficulties 
were secondary to physical or mental health problems, reduced this figure by 74 to 17. On 
further scrutiny, 8 articles were excluded for the following reasons: involved a 
benzodiazepine reduction programme (one study); included sleep onset and sleep 
maintenance difficulties (two studies); acknowledged that at least one (out of three)
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participant’s difficulties were secondary to depression (one study); difficulties due to sleep 
disordered breathing (one study); primary aim not to assess efficacy of treatment with 
results of sleep parameters reported elsewhere (two studies); baseline and treatment 
grouped together (ergo not allowing analysis of efficacy of treatment; one study). This left 
a total of 9 studies, with one further study being identified via hand-searching and 
consultation of reference lists (Edinger et al, 1992). This process was repeated by 
electronically searching the term sleep maintenance insomnia exclusively. No further 
studies were identified, giving a final total of 10 studies.
3.5 Data Extraction
The data extracted from each article included subject demographics; format and duration of 
treatment; and method of sleep assessment. In addition, sleep parameters reported included 
pre and post measures; wake time after onset (WASO); number of nocturnal awakenings 
(NOA); total sleep time (TST); sleep efficiency (SE); and sleep onset latency (SOL). 
Furthermore, data relating to study eligibility, quality and outcomes was derived. Due to 
the diversity of the study designs, and in order to make any comparison of studies 
meaningful, only immediate data were considered. Follow up data were not used for the 
purpose of this review.
3.6 Non-pharmacological Interventions Considered
Several non-pharmacological interventions were considered in this review. Bright light 
therapy (BLT; Campbell et al, 1993; Suhner et al, 2002) uses exposure to bright light 
timed to delay the circadian clock and thereby re-establish an appropriate phase
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relationship between the temperature rhythm and the timing of sleep to alleviate 
maintenance problems. Stimulus control therapy (SC; Bootzin et al, 1991) aims to train 
people with insomnia to reassociate the bed and bedroom with rapid sleep onset by 
restricting sleep incompatible behaviours that serve as cues for staying awake and by 
enforcing a consistent sleep-wake schedule. Sleep restriction (SR; Spielman et al, 1987) 
curtails the amount of time spent in bed to almost the amount of time asleep and creates a 
mild state of sleep deprivation which promotes more efficient sleep. Relaxation therapies 
(RT; Hoelscher et al, 1986) such as progressive muscle relaxation (tensing and relaxing 
muscles) are used to reduce arousal levels which people with PI often display. Paradoxical 
intention (PI; Broomfield & Espie, 2003) asks individuals with insomnia to engage in 
gently staying awake. This therapy draws on the basic premise that when an individual 
stops trying to sleep, performance anxiety and sleep effort are reduced and sleep comes 
more easily. Sleep hygiene education (SH; Hauri, 1991) targets health practices (e.g. 
exercise, substance use) and environmental factors (e.g. light, temperature) that may be 
either detrimental or beneficial to sleep.
Each of the above interventions includes only one component. Multi component cognitive 
behaviour therapy (CBT; e.g. Edinger et al, 2001; referred to as behaviour therapy in one 
early study in this review) employs a range of techniques, typically sleep restriction 
therapy, stimulus control, sleep hygiene education and cognitive restructuring. CBT aims 
to break the vicious circle of insomnia, emotional distress, dysfunctional cognitions, and 
further sleep disturbance. The cognitive restructuring element consists of identifying 
dysfunctional sleep cognitions, challenging their validity, and replacing them with more 
adaptive substitutes (Morin, 1993).
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3.7 Quality Ratings for Studies Considered
Two (complementary) measures were used to assess the methodological quality of the 
studies included. Firstly, the Methodological Quality Instrument (MQI; Cho & Bero, 1994) 
was used, an instrument which has been utilised successfully to assess the quality of 
pharmacological and non-pharmacological (Detsky et al, 1987) studies. The measure rates 
each study on several factors including design, inclusion/exclusion criteria, blinding of 
participants and raters, and statistical merit (see Figure 1). The MQI yields an overall score 
between zero and one, with one representing the highest possible quality.
INSERT FIGURE 1 HERE
Secondly, the Sleep Study Quality Measure (SSQM; Mendleson, 1997) was used. This is a 
measure specific to sleep, used successfully in a recent review (McMahon et al, 2005), and 
was employed here to determine quality of sleep-related aspects of the studies. The 
instrument takes into account subjective and objective measures of sleep, and examines 
details of reporting of sleep parameters. The SSQM also yields a score between zero and 
one, with one representing the highest quality (see Figure 2).
INSERT FIGURE 2 HERE
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A random sample of studies (n=4) were also evaluated by a second rater. Intra-class 
correlation co-efficients were calculated between both sets of ratings, and were high (0.99 
for the MQI and 1.00 for SSMQ). Disagreements between raters were discussed and a 
consensus on quality score reached for each measure.
3.8 Synthesis o f Results
Effect sizes were also calculated (where possible and not already available) as an indicator 
of treatment outcome. A standard mean difference score was calculated for each outcome 
variable by using Cohen’s d index of an individual effect size (Cohen, 1977), with the 
contribution of each study considered with respect to its quality rating.
4. RESULTS
Details of the papers that met criteria for inclusion are shown in Table 1. A summary of the 
sleep parameters extracted from each study is given in Table 2.
INSERT TABLE 1 HERE
4.1 Bright Light Therapy (BLT)
Two studies reported using BLT (Campbell et al, 1993; Suhner et al, 2002). One was a 
randomized placebo controlled trial (RCT; Campbell et al, 1993) and one was a
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randomized controlled relapse prevention trial (Suhner et al, 2002). These studies received 
quality ratings of 0.57 and 0.72 respectively on the MQI and 0.5 and 0.63 respectively on 
the SSQM.
Campbell et al (1993) carried out a placebo controlled trial with participants (mean age 
70.4 years) receiving 2 hrs of BLT each day for 12 days. Sleep parameters were measured 
using an electroencephalogram (EEG) and demonstrated a significant decrease in WASO 
from a mean of 102.8 mins to 43.2 mins in the active treatment group, as well as mean 
increase in SE of 17%, producing large effect sizes of 2.77 and 2.96, respectively. 
However, it is worth noting that even with this increase in SE, participants continued to 
spend an average of 43 minutes awake per night.
Campbell et al (1993) concluded their findings demonstrate the effectiveness of timed 
exposure to bright light in the treatment of this problem, and that with some refinements, 
BLT may prove useful in a large proportion of elderly people with sleep maintenance 
insomnia. However, the method of ‘randomisation’ employed is in particular a potential 
weakness in the study design. Participants were allocated to either treatment or control on 
an alternate basis. Thus, the sample was not truly randomized to condition. Furthermore, 
the investigators were not blind to this. Therefore, whilst the data suggests that BLT may 
significantly reduce time awake in bed, the study design may have introduced bias in terms 
of the allocation of participants to groups.
Suhner et al (2002) also used BLT in a relapse prevention study involving 15 participants 
aged 80 or over. In an open label phase, participants were given two hours exposure (at 
home) per day for 11-13 days, with sleep parameters primarily measured using
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polysomnography (PSG). According to the PSG data from the open label phase, no 
significant difference in WASO, SE or TST between the baseline and end of acute 
treatment phase was found. Furthermore, no significant difference between the active and 
control groups was observed on any sleep parameters after the maintenance phase.
Suhner et al (2002) therefore reported that no valid conclusion could be made about the 
efficacy of the maintenance treatment. Contrary to hypotheses, the acute light treatment 
phase did not improve sleep. A particular limitation of this study was the failure of the 
authors to use recognised subjective measures of sleep (e.g. sleep diary; Espie, 1991). A 
further limitation was the relatively small number of participants and, in particular, the 
relatively poor compliance of some participants. Finally, Suhner et al (2002) used paid 
volunteers, a potential confounding variable had any significant effect been found.
INSERT TABLE 2 HERE
4.2 Psychological Interventions
Eight studies using a combination of cognitive and behavioural techniques were reviewed. 
Seven used stimulus control (SC), three used sleep restriction (SR), three used education 
training (sleep requirements, effects of aging, circadian rhythms), one used relaxation 
therapy (RT), two used imagery training (IT), and one used sleep hygiene (SH). The 
quality ratings of these studies varied from 0.44 to 0.94 on the MQI, and 0.05 to 0.89 on 
the SSQM (see Table 1). To aid comprehension, studies are reported in accordance with
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their design. Four studies used randomised controls designs, one used a randomised design 
without a control, two used multiple baseline case series designs and one was a case study.
4.21 Randomised Controlled Trials
Edinger et al (2001) carried out a randomised double blind placebo controlled trial with 75 
participants, comparing CBT to RT and a placebo condition (quasi-desensitisation). 
Interventions consisted of 6 individual weekly sessions and sleep parameters were 
measured by subjective and objective means (sleep diary and PSG, respectively). CBT 
produced the largest improvements across the majority of outcome measures; sleep diaries 
showed that CBT-treated patients achieved an average 54% reduction in their WASO 
compared to 16% and 12% reductions for RT and placebo-treated patients, respectively. 
Recipients of CBT also showed a greater normalization of sleep and objective symptoms 
than the other groups, with an average sleep time of more than 6 hours and SE of 85.1% at 
treatment end.
In terms of quality, Edinger et al (2001) rated highly (0.94 on the MQI and 0.89 on the 
SSQM). They concluded that CBT represents a viable intervention for primary sleep- 
maintenance insomnia which should promote clinically significant sleep improvements 
within 6 weeks. Notable strengths of this study were the double blind design and the 
inclusion of a measure of treatment credibility, the Therapy Evaluation Questionnaire 
(Borkovec & Nau, 1972).
Lacks et al (1983) in their RCT compared SC to a credible placebo (quasi desensitisation) 
delivered in a small group format, with 15 participants. Sleep diaries were used for 
outcome measures. Both groups showed significant decrements in WASO and NOA, and
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there were no significant between group differences on any of the main dependant 
measures. They, however, noted that these non-significant differences were in the expected 
direction of SC being more effective.
A particular failing of this paper, aside from the small numbers, was the questionable 
conclusions regarding the results. Despite the lack of significant differences between 
treatment and control conditions, the authors later in the paper referred to the control group 
as a ‘control treatment’ after analysis of results, which prior to analysis had been described 
as the control group. Furthermore, the authors failed to confirm any of their sleep log data 
with objective measures. This is reflected in the poor quality rating of 0.18 on the SSQM. 
To their credit, the authors did attempt to account for both therapist effect and treatment 
credibility. However, participants were also required to pay for postage and a ‘deposit’ 
for taking part, which could be ‘earned back’ through participation in sessions. This may 
have increased participants’ investment in symptoms improving. These design limitations 
meant this study attracted a lower quality score on the MQI (0.58) than the Edinger et al 
(2001) study.
Morin and Azrin (1987) compared the efficacy of SC and IT to a wait list control (WLC). 
Seven participants formed each of the three groups (total N=21), with treatments delivered 
in a small group setting. Results showed that SC produced a larger and quicker impact on 
awakening than IT. The SC group’s mean WASO reduced by 65% compared to 16% in the 
IT group and 25% in the WLC.Furthermore, both the SC and IT group showed a greater 
reduction in NO A compared to WLC. However, there was no significant difference 
between SC and IT on this variable.
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Morin and Azrin (1987) concluded that behavioural and cognitive procedures such as SC 
and IT may provide substantial benefits in alleviating maintenance insomnia. The study 
had several limitations, however, and was of moderate quality according to the MQI, with 
a rating of 0.66. One obvious limitation is the small numbers per group (N = 7). The 
absence of objective sleep data to confirm the subjective sleep results (diary) also led to the 
low quality rating attracted on the SSQM (0.21). Moreover, reporting of data was vague, 
with exact figures per group for each outcome measure not reported.
Morin and Azrin (1988) also completed a randomised controlled trial comparing SC and IT 
with WLC. This study used a similar group format as their previous trial, although this 
time only participants specifically aged 55 and over were recruited. Furthermore, on this 
occasion, an objective sleep assessment device was employed (SAD; a remote hand-held 
switch which participants pressed whilst awake, which was connected to a clock). Both SC 
and IT produced a significant improvement on sleep diary measures, with large effect sizes 
on WASO of 0.84 and 0.61 respectively. WASO for the SC group reduced significantly 
relative to WLC, although the IT group did not differ significantly from either group on 
this measure. In this respect, the mean WASO was reduced for the SC group by 33.86 min 
compared to a 16.22 min reduction in the IT group, and an increase in the WLC’s of 3.9 
mins. Similarly, the SC group’s TST increased significantly more than either of the other 
groups. Furthermore, satisfaction with treatment progress was higher for the SC than IT 
group and was perceived to be more ‘credible’.
The authors therefore concluded that SC and IT can effectively treat maintenance 
difficulties in older adults. However, although the study made an attempt to use objective 
measures, these were not included as outcome data and were only used to correlate with
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subjective measures (these correlations were significant). In addition, the interventions 
were ‘superimposed’ on drug intake for some participants, thereby confounding treatment 
outcome results. Moreover, participants with physical illnesses were included if their 
insomnia was not considered secondary to a physical illness. And participants were 
required to pay a deposit before participation. This may have confounded the results, as 
any remitting of physical symptoms may have had a secondary effect on sleep independent 
of intervention. Furthermore, financial investment may have meant participants had a 
vested interest in symptoms improving. This study yielded quality scores of 0.70 and 0.29, 
respectively on the MQI and SSQM.
4.22 Randomised Trials
Schoicket et al (1988) compared meditation, SC, and SH in 65 adults in a four week 
treatment programme conducted in small groups. Outcome was measured using sleep 
diaries. There was no control condition but, notably, both the SC and meditation group 
were also given SH instructions. Participants were also given counterdemand instructions 
“not to expect improvement to sleep until after the fourth treatment session” to reduce 
demand effects (Steinmark & Borkovec, 1974). Results were analysed in week 3 and 4 
because of the counterdemand instructions. Participants in all three groups achieved 
significant improvement from baseline during the 4 weeks of treatment. There were no 
statistical differences between any of the groups. Taken together, the treatments produced a 
31% decrease in WASO and a 20% decrease in the NOA after 4 weeks (see Table 4 for 
individual results). Furthermore, it appears these findings were not the result of demand 
characteristics; a significant difference was gained first at week 3 and maintained at week 
4, despite instructions not to expect improvement until week 4. Indeed, meditation and SC
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produced large effect sizes of 0.95 and 0.78, respectively. SH produced an effect size of 
0.47.
The authors, therefore, concluded that improvement can be attained in a brief period by 
group treatment using either of these techniques. This study was limited by the lack of 
objective measures of sleep (reflected in its low quality rating of 0.18 according to the 
SSQM), and the lack of control group. Furthermore, like the some of the previous studies 
reviewed, participants were required to pay postage and a deposit in advance of 
participation. The authors did at least attempt to control for demand characteristics, and 
measured treatment compliance and credibility/acceptability. This study therefore gained a 
larger quality rating on the MQI (0.74) than the SSQM (0.18).
4.23 Case Series
Hoelscher & Edinger (1988) used a multiple baseline design to evaluate a behavioural 
treatment (BT) package which included SR, SE and SC in four ‘older adults’ aged 59 to 
72. Intervention was delivered via 4 individual weekly sessions. Diary and SAD measured 
sleep. A clinically significant reduction in WASO was found in three participants. Mean 
subjective and objective WASO reduced by 52.3 min (ES = 1.44) and 53.8 min (ES = 
1.30), respectively. SE also increased on both measures, however, these benefits did not 
translate to increased TST. Moreover, one participant failed to make improvements, 
although using PSG, the authors identified a fragmented sleep pattern secondary to 
periodic leg movements.
Hoelscher & Edinger (1988) described their results as “encouraging” but called for further 
controlled evaluations. The study was not of particularly high quality according to the MQI
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and SSQM (0.51 and 0.50, respectively). The limitations of this study are rather obvious, 
in that they used only a very small sample (N=4) and no control group.
Edinger et al (1992) also used a multiple baseline design to treat seven ‘older adults’ aged 
55 to 68 years sequentially with RT and then a CBT package (which included SE, SC and 
SR). They delivered both interventions on a weekly basis for four weeks each. Sleep 
diaries and SAD measured change. Only modest improvements in WASO and SE were 
found after RT. This compared to significant improvements observed following CBT. On 
sleep diaries, mean WASO reduced from 103.7 min in the baseline condition to 37.9 min 
post CBT (ES = 1.62) and SE increased by 13.6% (ES = 13.85). This difference was more 
pronounced according to the SAD data which saw mean WASO reduced from 167.0min to 
48.5min and SE increase by 22%.
Edinger et al (1992) described their results as promising in terms of CBT efficacy, but 
conceded the limitations of their study as the small sample size and relatively high 
educational levels of participants. Furthermore, the study appears to use PSG which is 
arguably a more robust objective measure of sleep. However, PSG data were not fully 
reported and analysed. This study gained scores of 0.45 and 0.61 on the MQI and SSQM 
respectively.
4.24 Case Study
Espie and Lindsay (1987) reported a case study using time series analysis of a 33 year old 
man with sleep maintenance insomnia. They used Paradoxical Intention (PI) weekly, over 
6 weeks, followed by worry control (WC) for 3 weeks. WC comprised of elements of
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cognitive restructuring and behavioural problem solving. PI made little impact upon 
WASO. However, WASO fell from a mean of 52 minutes at baseline to 14 minutes during 
WC. Statistical analysis using time series analysis confirmed the visual impression of a 
significant change resulting from WC but not PI.
The authors concluded results did not support the use of PI but strongly favoured WC as a 
means of reducing mental arousal and WASO. This study gained one of the lowest scores 
of 0.44 and 0.05 on the MQI and SSQM respectively, which is perhaps not surprising 
given the case study design. The obvious limitations of generalising from a case study are 
applicable. Furthermore, the study did not detail sleep parameters at onset. However, the 
authors did attempt to use formal, recognised statistical procedures in the form of time 
series analysis.
5. SUMMARY
5.1 Limitations o f Research
Consideration of the evidence for the non-pharmacological interventions reviewed here 
must be taken in context of the general limitations to the currently available literature. 
When looking at the literature overall it is striking to note that, in general, many of the 
studies focused on (poorly defined) older adult samples. Yet maintenance problems also 
predominate in middle aged samples. Indeed, no studies of BLT have been completed 
using younger adults with maintenance problems.
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Furthermore, the quality of the studies varies considerably. This can be seen in the range 
of MQI and SSMQ ratings. Overall, the MQI ratings vary from 0.44 to 0.94 and the SSQM 
ranges from 0.05 to 0.89. Only two of the studies reviewed (Suhner et al, 2002; Campbell 
et al, 1993; Edinger et al, 2001) used formal diagnostic criteria to identify sleep 
maintenance insomnia. Several studies paid participants, or asked them to pay for postage 
or a deposit which could be earned back in treatment (Suhner et al, 2002; Lacks et al, 
1983; Shoicket et al, 1988; Morin & Azrin, 1988). This may very well have influenced the 
investment that participants had in these interventions improving their sleep. This is of 
particular relevance given that many studies comparing different treatment components 
found significant effects for all groups, with no significant differences between them. 
Many studies also involved small numbers of participants and, without fail, all studies 
failed to report a power calculation. Only a minority of studies used both objective and 
subjective measures of sleep (Campbell et al, 1993; Hoelscher & Edinger, 1988; Edinger et 
al, 1992).
Future research should consider focussing on more carefully controlled trials with larger 
sample sizes, explicitly stating diagnostic criteria used for inclusion, and using power 
calculations to detect the likelihood of identifying change. They should also ensure the use 
of unpaid volunteers and carefully delineate intervention components using control groups 
as comparisons.
5.2 Bright Light Therapy
Only two RCT’s of BLT met criteria for this review with a total of only 31 participants. 
Evidence was contradictory and the quality of the evidence was variable and, at best, 
reasonable. Campbell et al (1993) found BLT to be effective compared to a placebo but
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Suhner et al (2002) did not. Indeed, the one study which found a significant effect for BLT 
(Campbell et al, 1993) was the poorer in quality of the two. Further research is required to 
replicate the study designs of those reviewed using larger samples whilst clearly defining 
the diagnostic criteria used and ensuring that investigators are also blind to the nature of 
intervention given. Finally, there is a clear need for research in the area of BLT with 
younger adults suffering from maintenance insomnia.
5.3 Psychological Interventions
The primary aim of this review was not to compare individual psychological interventions, 
rather to identify whether these interventions may be of benefit. However, evidence for 
each intervention was not equivalent and, therefore, it appears appropriate to discuss the 
evidence of each intervention in turn.
There is some evidence for the use of multi component CBT for maintenance problems. It 
was found to have significant benefits in three studies (one RCT and two case series) with 
a total of 86 participants of mixed age. In two of these studies CBT was found to be 
superior to RT (Edinger et al 1992; Edinger et al, 2001), with no control group in the 
remaining study (Hoelscher & Edinger, 1988). Although the quality on these studies varied 
greatly (from 0.45 to 0.94 on the MQI and 0.5 to 0.89 on the SSQM), it is noteworthy that 
one of these studies (Edinger et al, 2001) had the highest quality rating of all the studies 
reviewed. Furthermore, these three studies were the only in this review to use both 
subjective and objective measures to identify change.
There is also evidence for the specific use of SC, but it is not clear whether this is more 
effective alone than other interventions. Four studies totalling 128 participants, 3 of which
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were RCT’s, compared SC to various other interventions and placebos. SC was found to 
significantly improve WASO without exception, as well as various other sleep parameters 
to varying degrees. However, in all but one of these studies (Morin and Azrin, 1987), no 
significant differences were found between SC and other interventions/controls. 
Nevertheless, one study showed a trend toward improvement compared to a placebo 
(Lacks et al, 1983) and another yielded greater (though not significant) improvements 
compared to IT (Schoicket et al, 1988). These studies varied in quality from reasonable to 
good on MQI (0.58 to 0.74) but low rates according to the SSQM (0.18 to 0.29). This 
reflects the fact that none of the studies used objective measures. However, all studies with 
the exception of Morin and Azrin (1987), required participants to pay for postage and a 
deposit. It is interesting to note that the only study which did not was also the only one that 
found a significant difference between SC and the other conditions. This could indicate 
that the significant results for all interventions in other studies may partially be reflective 
of an investment participants made in ‘getting better’.
There is at present insufficient evidence for the use of SH and meditation. Both were 
shown to have significant effects in a study involving 65 participants. This work found 
significant improvements delivering SH and meditation in small groups (Schoicket et al, 
1988). However, no benefit was found with these interventions, relative to SC. This study 
was a randomised trial, albeit without a placebo and as such was judged to be of good 
quality on MQI (0.74). Again however, it did not assess sleep parameters objectively 
required participants to pay a deposit/ postage and packaging, reflected in its low quality 
rating on SSQM (0.18).
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Evidence for the use of IT or WC is also insufficient at present. IT was found to be of 
benefit in one RCT with 27 participants (Morin & Azrin, 1988), although results were not 
superior to SC on WASO. However, the same improvements were not replicated in a 
similar study with 21 participants (Morin & Azrin, 1987) of comparable (if slightly lower) 
quality. WC was found to be of significant benefit in one case study (Espie & Lindsay, 
1987) in that reductions of WASO were found while engaging in WC but not PI. However, 
given the poor quality and the nature of the design, this is considered insufficient evidence 
for the use of this intervention in this population.
5.4 Review Limitations
The limitations of the current review should be borne in mind when considering its 
conclusions. The volume of literature reviewed was small, with a total of ten studies 
reviewed in total. Furthermore, this paper did not rate evidence according to the ‘levels of 
evidence approach’ (c.f. Morin et al, 1999), although it does discuss the relative quality of 
each study. Hence, conclusions are given with the above caveats in mind.
5.5 Conclusions
Non-pharmacological interventions are fairly well established in the treatment of initial 
insomnia but effects on sleep maintenance problems are unclear. This review assessed the 
effectiveness of non-pharmacological interventions for sleep maintenance insomnia in 
adult and older adult populations. The quality of studies reviewed varied greatly. Many 
involved small samples and a surprising amount required participants to ‘pay to take part’. 
There was very little convincing evidence for the effectiveness of BLT from the limited
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studies reported here, and both studies reviewed used older adults exclusively. There 
appears sufficient evidence to suggest that psychological interventions, in general, are 
effective in treating sleep maintenance insomnia. In particular, there appears stronger, 
better quality, evidence for the use of multi component CBT. However, there is less 
evidence to indicate which specific components of CBT treatment packages are the most 
effective, with almost all being found effective in at least one study, but little difference 
between them. Further controlled trials of unpaid volunteers of mixed ages are therefore 
required to carefully delineate which intervention components are most effective in the 
management of maintenance insomnia difficulties.
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Figure 1.
M ethodological Q uality Instrum ent (Cho & Bero. 1994)
Reviewer: Article Number:
1. Study Design (choose 1 only):
Experimental, randomised Placebo-
controlled tr ia l Comparative trial, no
placebo Time series trial 
Crossover trial
Nonexperimental Cohort,
prospective  Cohort, retrospective
Cross-sectional Case-control 
 Case reports or case series
 None o f the above (describe below):
2. What was the study question? (please use the space below)
[possible responses to items 3-24: _  Yes _  Partial_ No _  (Not applicable)
3. Was the study question sufficiently described?
4. Was the study design appropriate to answer the study question?
5. Were both the inclusion and exclusion criteria specified? ( if  case study check N/A)
6. For case studies only: Were participant characteristics adequately reported? (If not case 
study, check N /A )
7. Were participants appropriate to the study question?
8. Were control participants appropriate? (If no controls were used, check N /A.)
9. Were participants randomly selected from the target population?
10. If participants were randomly selected, was the method o f  random selection sufficiently well- 
described? (If participants were not randomly allocated, check N /A .)
11. If participants were randomly allocated to treatment groups, was the method o f  random allocation 
sufficiently described? (If participants were not randomly allocated, check N /A.)
12. If blinding o f  investigators to intervention was possible, was it reported? (If not possible, check N /A.)
13. If blinding o f  participants to intervention was possible, was it reported? (If not possible, check N /A.)
14. Was measurement bias accounted for by methods other than blinding?
15. Were known confounders accounted for by study design? (If no known confounders, check N/A.)
16. Were known confounders accounted for by analysis? (If no known confounders, check N/A.)
17. Was there a sample size justification before the study?
18. Were post-hoc power calculations or confidence intervals reported for statistically non­
significant results?
19. Were statistical analyses appropriate?
20. Were the statistical tests stated?
21. Were exact p  values or confidence intervals reported for each test?
22. Were attrition o f  participants and reasons for attrition recorded?
23. For those participants who completed the study, were the results completely reported?
24. Do the findings support the conclusions?
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Figure 2.
Sleep Study Quality M easure (Derived from M endelson. 1997)
Reviewer: Article Number:
1. Self-report measure used to assess sleep quality (1 point)
Sleep parameters reported for PI studies only (0.5 points for each): WASO, SOL, TST
Sleep parameters reported for DSPS studies only (0.5 points for each): Sleep Onset and 
Sleep Offset, TST
2. Objective measure PSG (2 points) and/or actigraphy (1 point) used (Maximum 3 Points)
Sleep parameters reported for PI studies only (0.5 points for each): WASO, SOL, TST
Sleep parameters reported for DSPS studies only (0.5 points for each): Sleep Onset and 
Sleep Offset, TST
3. Appropriate diagnostic measures used to assign diagnosis, and clear assessment and 
exclusion o f  other sleep disorders; e.g., apnoea. (2 points for Yes; 1 for Partial)
4. Measures o f  clinical significance reported (1 Point) or sufficient data quoted to be able to 
calculate (0.5 points).
Weighting Scheme: Points in 1, 2 and 3 multiplied by two.
Points in 4 multiplied by one.
Total Possible Points: 19
Quality Rating: Actual S co re /19
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Chapter 3
MAJOR RESEARCH PROJECT PROPOSAL
Does a Pennebaker-like writing intervention reduce cognitive arousal 
and sleep onset latency in poor sleepers?
Major Research Proposal submitted in partial fulfilment of the requirement for the degree 
of Doctor of Clinical Psychology (Appendix 3.1)
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Summary
This study draws on several areas of literature including the role of cognitive arousal in 
sleep difficulties and a cognitive model of insomnia implicating inhibition and suppression 
as maintaining insomnia. The Pennebaker writing task requires people to write about their 
innermost thoughts and emotions regarding traumatic or significantly emotional events and 
is thought to promote emotional processing or facilitate cognitive changes that increase 
insight. This task has had significant effects in several areas of psychological and physical 
ill health. Furthermore, a pilot study using a Pennebaker-like writing task with poor 
sleepers proved successful. This study aims to test the notion that a Pennebaker-like 
writing task will reduce pre sleep cognitive activity and the length of time it takes for 
individuals to fall asleep (sleep onset latency; SOL). This study will do this by replicating 
and extending on an existing pilot study. A minimum of 28 participants will be 
randomised, following a one night baseline, to three nights of Pennebaker writing, or a 
control condition. A mixed models ANOVA design will be employed with the between 
participants factor of condition (Pennebaker, Control) and within group factor of Time 
(Baseline, Treatment). It is hypothesised that, following a one night baseline, participants 
randomised to the experimental condition (Pennebaker - like writing task), when compared 
with participants randomised to the control condition will show reduced pre-sleep 
cognitive arousal and reduced SOL.
Databases searched include: PsycINFO, Medline, All EBM Reviews, Social Sciences 
Citation Index.
Keywords searched include: insomnia, Pennebaker writing, cognitive arousal and various 
authors' names.
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Background
Cognitive arousal in sleep difficulties
The role of cognitive arousal is well established in sleep difficulties (Espie, 2002). There is 
an emerging consensus that pre sleep cognitive activity of people with insomnia is 
typically negatively toned and covers a broad range of topics (Harvey, 2000; Wicklow and 
Espie, 2000). Most individuals with sleep onset insomnia “complain that the sleep onset 
period is dominated by unwanted thoughts and worries, as well as periods of rumination 
about past or future life events, or concerns about the placations of not being able to fall 
asleep” (Harvey, 2003, p. 594; Borkovec, 1982; Espie, 1991). Furthermore, these 
individuals frequently perceive this activity as a major barrier to sleep (Espie, Brooks and 
Lindsay, 1989; Harvey, 2000). For example, Lichstein and Rosenthal (1980) found that 
people with insomnia are ten times more likely to quote cognitive arousal as central to their 
sleep disturbance compared to somatic arousal. However, there is evidence that such 
cognitive arousal can be reduced. A study by Harvey and Payne (2002) found that 
thinking about a specific interesting and engaging cognitive task to be an effective method 
of managing unwanted pre-sleep thoughts among people with insomnia in the short term.
Inhibition and suppression in insomnia
There is also some evidence that insomniacs inhibit or internalise their emotions (Kales, 
Caldwell, Soldatos, Bixler and Kales, 1983; Kales and Kales, 1984). Kales et al (1983) 
used the Minnesota Multiphasic Personality Inventory (MMPI) to assess personality 
patterns of 528 patients with chronic insomnia. The profiles these patients were
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consistently characterised by, amongst other things, inhibition of emotions. Harvey’s
(2002) cognitive model of insomnia draws on these findings and suggests that “it is 
possible that inhibition and suppression may be a strategy adopted to cope with excessive 
cognitive activity and escalating anxiety throughout the day” (Harvey, 2002, p.884). 
According to this model, as a result, the unwanted pre sleep cognitive activity reported by 
those with insomnia may (in part) be a consequence of this inhibition and incomplete 
emotional processing of daily stressors. It is proposed that the resulting ‘unfinished’ 
business from the day intrudes during the pre sleep period, fuelling negatively toned pre 
sleep cognitive activity and interfering with sleep onset. This proposal is by and large 
untested, although Harvey (2001) did find that suppression was employed more by 
insomniacs than good sleepers when dealing with intrusive thoughts or worries when 
trying to get to sleep. Nevertheless, emotional processing theory by Rachmann (1980) 
would support such a view and Bootzin and Rider (1997), amongst others, acknowledge 
that bed time might possibly be the first quiet time during the day that an individual has to 
think about the day’s events as well as to worry and plan for the next day.
Further evidence in line with the idea that people with insomnia do not adequately process 
events of the day are results from studies indicating that insomniacs engage in problem 
solving (Harvey, 2000) and reappraisal (Harvey, 2001) whilst trying to get to sleep. For 
example, Harvey (2001) compared the strategies employed to manage cognitive activity 
during the pre sleep period of 30 insomnia sufferers with 29 good sleepers and found that 
one of the most frequently used strategies for insomnia sufferers, but not good sleepers, 
was reappraisal. Thus, it could be argued that insomniacs engage in these strategies in 
order to compensate for their failing to process these worries adequately during the day.
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Writing paradigms
The experimental work of Pennebaker and his colleagues (e.g. Pennebaker and Beall, 
1986; Pennebaker, Kiecolt-Glaser and Glaser, 1988) has consistently found that inducing 
participants to write about their innermost thoughts and emotions regarding traumatic or 
significantly emotional events resulted in health improvements. Respondents who were 
asked to disclose their emotional reactions to past traumatic events or recent upsetting 
experiences subsequently made fewer visits to physicians than did individuals who had 
been instructed to write about neutral topics (Pennebaker and Beall, 1986).
With specific regards to psychological wellbeing, recent results show that written 
disclosure buffered the effects of social constraints on stress in cancer patients at 6-month 
follow-up (Zakowski, Ramati, Johnson, Morton and Flanigan, 2004). This study 
randomised participants to a written emotional disclosure task or a ‘non emotional’ writing 
task. Their results showed that written disclosure buffered the effects of social constraints 
(negative social responses to patients' expressions of emotion regarding their cancer) on 
distress such that patients with high levels of constraint at study intake exhibited distress 
levels comparable to patients with low levels of constraint, if they were given the 
opportunity to express their emotions in writing. Those at high constraint levels who were 
not given that opportunity (control condition) continued to exhibit heightened levels of 
distress at follow-up.
Although the expressive writing paradigm has generally produced positive outcomes, a 
recurring puzzle concerns how and why it works (Pennebaker, 2004; Bootzin, 1997). No 
single theory or theoretical perspective has convincingly explained its effectiveness
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(Pennebaker, 2004), although two theories predominate the literature. One theory is that 
writing about emotions reverses emotional inhibition and facilitates emotional processing. 
A second theory argues that writing facilitates cognitive changes that increase insight 
(Pennebaker, 1997). Nevertheless, Bootzin (1997) has highlighted the potential utility of 
Pennebaker’s writing intervention to be a component for treatment of some disorders, but 
emphasised the need for prior systematic research into its benefit with specific clinical 
problems.
Writing in sleep difficulties
Several investigations have looked at the role of writing in sleep difficulties. Espie and 
Lindsay (1987) have described a technique (cognitive control) which aims to reduce the 
influence of cognitive activity upon sleep which includes pre sleep writing. However, the 
task instructions in this study were different to that of a Pennebaker-like writing task and 
included focussing on the days worries and evaluating them as well as creating a ‘to do 
list’. Furthermore, the overall aims of this intervention were different to that of the 
Pennebaker task, primarily being to remove mental activity from the bed and bedroom 
environment (Morin and Espie, 2003), rather than facilitating emotional processing.
In addition, Krakow et al (2001) and Neidhardt et al (1992) found that exposure 
interventions for nightmare sufferers that include writing were successful in reducing the 
frequency of nightmares and improved sleep quality. These data further suggest that 
nocturnal writing tasks may have potential in the amelioration of sleep disturbance via 
facilitation of emotional processing.
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With regards to the work of Pennebaker and colleagues, a pilot study carried out by 
Harvey and Farrell (2003) found that a Pennebaker-like writing task led to shorter 
estimated sleep onset in poor sleepers when compared to individuals who did not engage 
in this task. As this study was pilot in nature, there were several methodological 
limitations that preclude drawing strong conclusions from this work.
Firstly, the sample were poor sleepers, which were employed as an analogue of insomnia. 
Thus, firm conclusions cannot be drawn regarding the implications of the results of this 
study for understanding and treating insomnia. Secondly, the rational given to the group 
completing the Pennebaker-like writing task explicitly led them to expect that the writing 
task would be beneficial to sleep. This could mean that results reflect a placebo effect 
(Bootzin, Herman and Nicassio, 1976). Thirdly, sleep onset latency was exclusively 
measured using the subjective reports of participants. The accuracy of any results 
measured by this means might be questioned as individuals with insomnia are known to be 
inaccurate in their estimation of sleep onset latency (Coates et al, 1982). Fourthly, no 
baseline period was employed in this study. Although no pre intervention differences were 
found between groups in terms of sleep onset latency, this measure was taken 
retrospectively for an average night. Given the inaccuracy of insomniac in reporting sleep 
onset latency (Coates et al, 1982) and the fact that sleep has much inter-subject and inter­
night variability (Speilman, Yang and Glovinsky, 2001), this makes it difficult to exclude 
the explanation that the change in sleep variables are not simply an artefact of inter-subject 
variability or change to habitual bedtime/wakening. Finally, no measures were included in 
this study to clearly determine the mechanism by which the intervention group 
experienced shorter sleep onset latency, for example, pre sleep cognitive arousal.
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Summary
In summary, the following points should be considered:
■ The evidence for the role of cognitive arousal in sleep difficulties.
■ Harvey’s (2002) model implicating inhibition and suppression as maintaining 
insomnia.
■ The proposed theoretical underpinnings of the utility of the Pennebaker writing task.
■ The significant effects of Pennebaker writing in other areas, along with the (limited) 
evidence of therapies utilising writing in sleep.
■ The pilot study using a Pennebaker-like writing task with poor sleepers.
Taken together, these factors could indicate that engaging individuals with insomnia in 
Pennebaker-like writing task would lead to a reduction in pre sleep cognitive activity as 
well as a reduction in sleep onset latency.
Study Aim
This study aims to test the notion that a Pennebaker-like writing task will reduce pre sleep 
cognitive activity and the length of time it takes for individuals to fall asleep (sleep onset 
latency; SOL). This study will do this by replicating and extending on the existing pilot 
work of Harvey and Farrell (2003), by addressing the methodological limitations 
mentioned above.
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Design
The independent variable is the ‘condition’; participants will be randomised, following a 
one night baseline, to three nights of Pennebaker writing, or a control condition. The 
dependent variables are SOL and pre sleep cognitive activity. A mixed models ANOVA 
design will be employed with the between participants factor of condition (Pennebaker, 
Control) and within group factor of Time (Baseline, Treatment).
Hypothesis
It is hypothesised that, following a one night baseline, participants randomised to the 
experimental condition (Pennebaker - like writing task), when compared with participants 
randomised to the control condition will show:
1. Reduced pre-sleep cognitive arousal.
2. Reduced SOL.
Participants
The minimum number of participants required in a study of this nature to ensure that any 
significant result would be of a meaningful magnitude is 28 (N = 14 per group). This 
number was derived from a two sample normal distribution with unequal variances power 
calculation by means of a t-test using Welch's approximation for the degrees of freedom. A 
website power calculator (http://calculators.stat.ucla.edu/powercalc/) was used to carry out 
this analysis. The extant data of means and standard deviations of SOL from both the
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experimental and ‘sleep as usual’ condition from Harvey and Farrell (2003) was used as a 
template, with the power set at 0.8 and the alpha level being p< 0.05.
Participants will be recruited via notices placed locally and emails sent to University and 
Health Service Staff via a mass mailing system asking for volunteers with sleep 
difficulties, a method which has previously proved successful (e.g. Broomfield and Espie, 
2003). Current third year trainees are successfully recruiting in this manner also. 
Participants will be aged between 16 and 65, be required to meet formal criteria for sleep 
onset insomnia according to the revised version of the International Classification of Sleep 
Disorders (American Sleep Disorder Association, 1997; i.e. SOL greater than 30 minutes 
on at least 4 nights a week, with or without disruption to other sleep variables), and 
complain of poor sleep due to excessive pre sleep worry/cognition. Exclusion criteria will 
include failure to comply with instructions of the task, the use of alcohol or sleep 
medication during the experimental period, severe depression or physical illness during the 
study period.
Measures
■ A structured clinical interview that includes questions to establish the presence or 
absence of each ICSD criteria for insomnia and to exclude other mental health 
problems or sleep disorders. This interview has been developed by members of the 
Sleep Group at Glasgow University and will be used to screen for insomnia and 
mental health problems, in the absence of a psychometrically validated alternative.
■ The Insomnia Severity Index (Morin, 1993). The ISI is an index of insomnia 
severity. It has been validated against both polysomnographic and prospective sleep
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diary measures and demonstrates convergence with clinical interview criteria. It 
demonstrates face and criterion validity, and other adequate psychometric 
properties. It provides a cut-off score which is considered useful as a guideline for 
clinicians in evaluating the clinical significance of the insomnia complaint. A cut­
off score of 14 demonstrates a sensitivity of 94% and a specificity of 94% in 
distinguishing individuals diagnosed with primary insomnia from good sleeper 
controls. This measure will also be used to screen for insomnia.
■ Pittsburgh Sleep Quality Index -  PSQI (Buyesse et al, 1993). The PSQI requests 
information regarding the number of hours spent in bed and asleep, frequency and 
reasons for awakening, and difficulty returning to sleep after awakening. The PSQI 
has been shown to be a valid and reliable assessment to overall sleep quality and 
disturbance, with good test-retest reliability (r = 0.85) and internal consistency 
([alpha] = 0.83). This is would also be used to screen for insomnia, alongside the 
semi structured interview.
■ The Beck Depression Inventory II (BDI-II; Beck, Steer & Brown, 1996) will be 
used to aid screening for severe depression. This is a self-administered 21 item 
self-report scale measuring supposed manifestations of depression. It has good 
psychometric properties and there are widely agreed cut-offs based on scores 
indicating from no depression or minimal depression to mild, moderate, or severe 
depression.
■ A daily sleep diary (Espie, 1991) to measure sleep onset latency and pre sleep 
cognitive activity. This diary requests information on: time to bed, time to fall 
asleep, and total sleep time.
■ The cognitive subscale of the Pre Sleep Arousal Scale (PSAS; Nicassio et al, 
1985). The PSAS contains 16 items tapping eight symptoms of cognitive (e.g.,
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racing mind) and eight symptoms of somatic (e.g., muscle tension) arousal 
experienced at bedtime. Ratings range from 1 (not at all) to 5 (extremely). A total 
score ranging from 8 to 40 is computed for each subscale; a high score indicates a 
high arousal. The internal consistency and the test-retest reliability of this 
questionnaire are adequate. Participants will be instructed to complete the cognitive 
subscale of this measure on rising in the morning, along with the sleep diary.
■ “Actiwatch” (model AW2; Cambridge Neurotechnology Ltd). This wrist actigraph 
recording provides objective estimates of SOL and sleep efficiency. This measure 
assesses levels of movement which is known to be a good predictor of wakefulness 
and sleep (America Sleep Disorders Association, 1995; Mullaney et al., 1980). 
Actigraph measures correlate highly with polysomnographic (PSG) data for sleep 
duration and total wake time (Sadeh et al., 1995; Mullaney et al., 1980).
■ A rating of ‘emotional processing’ using a 4 point scale (“I worked through some 
upsetting issues”; anchor points 0 “not at all”, 3 “a lot”). In the absence of any 
psychometrically validated alternative, this will be used as a measure of the extent 
to which individuals thought that they emotionally processed information after 
engaging in the writing task
■ The Penn State Worry Questionnaire (PSWQ; Meyer et al, 1990). This 
questionnaire will not be used for diagnostic or analysis purposes, it will solely be 
used to ensure that the control group are focussed upon worry for a similar length 
of time of the experimental group.
■ The Worry Domains Questionnaire (WDQ; Tallis, Eysenk, and Mathews, 1992). 
As with the PSWQ, the results from this will not be analysed, but will be used to 
ensure that the control group was focussed on worry for the same amount of time as 
the experimental group.
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Procedure
After screening, participants will be given instructions in how to complete the sleep diary 
and use the actiwatch. Participants will be instructed to wear the actigraph watch every day 
and complete the sleep diary on waking.
Participants will have previously been randomised to either the experimental task or the 
‘sleep as usual’ condition using a 'random number generator' website such as 
http://www.Random. or g. Participants will be given two envelopes containing instructions 
for day 1 and instructions for days 2 to 4 (which they will be told not to open until that 
day), as well as sleep diaries and copies of the relevant questionnaires.
Participant’s sleep will be monitored for a 1 day baseline period (day 1). Participants will 
then be asked to follow the instructions below, relevant to their particular condition, for a 
further 3 days (days 2 -  4). Such a timescale has proved sufficient to find adequate results 
in similar experimental studies manipulating novel interventions (e.g. Harvey and Payne, 
2002; Haynes et al, 1981; Harvey, 2003). Indeed, Harvey and Farrell (2003) found a 
significant effect over 3 days in their pilot study using the same task.
As patients' expectations have been known to influence response to other interventions 
(Espie and Lindsay, 1985; Broomfield and Espie, 2003), all participants will be told that 
they should not expect any improvement in sleep. Adherence to the experimental 
condition will be monitored using a manipulation check to similar to that of Harvey and
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Farrell (2003). This would ask participants to rate the content of their writing on a scale 
from -5 (about sad/anxiety related things) to +5 (about happy things).
At the end of the study, all participants will be debriefed and thanked. Participants will also 
be issued with the ‘Good Sleep Guide’, a leaflet describing behavioural advice for home 
practice (National Medical Advisory Committee, 1993).
Experimental condition
Participants in the experimental condition will be given written instructions based on those 
used by Harvey and Farrell (2003) and Pennebaker (1997). See Appendix 4.5 for a copy of 
the participants’ instructions. Participants will be asked to write about any thoughts, 
concerns, worries for 20 minutes in the early evening (between 6pm and 8 pm). This time 
was chosen as it was thought that engaging in such a task at bedtime may be activating, 
and would therefore be too arousing to be effective. In addition, Espie and Lindsay (1987) 
suggested targeting pre sleep worry in the early evening might be more effective than 
procedures at bedtime. Participants will be instructed to engage in this activity outwith the 
bedroom, in order to ensure that the worries they write about (which are incompatible with 
sleep) do not become associated with the bedroom environment (Bootzin, 1972/ 
Participants will also be asked to complete the ‘emotional processing rating’ after engaging 
in this task.
Participants will be instructed that they can write about either the same or different 
traumatic events during each writing session. Despite suggestions by Harvey and Farrell
(2003) to the contrary, participants will not be required to show anyone what they write (to
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encourage honest and free emotional expression), and this will be made explicit to them in 
the first instance.
Control group
The control group will be instructed to complete a PSWQ and WDQ between 6pm and 
8pm in order that they spend approximately the same amount of time focussed on their 
worries as the experimental group, but without facilitation of emotional processing that the 
Pennebaker task is hypothesised to facilitate. In addition, the control group will be asked to 
carry on with their normal sleeping practices, to continue wearing their Actiwatch and to 
continue completing their sleep diary.
Analysis
An average SOL will be calculated for both the baseline and experiments phase. Both 
groups would then be compared on this, and the PSAS cognitive subscale, by means of a 
two way mixed ANOVA with the independent variables being Condition (writing task v 
control) and Time (Baseline vs Experimental Phase). Separate ANOVAs for SOL and 
cognitive activity will be computed.
Discussion
The results of this study will provide further evidence for the efficacy of this intervention 
and its effects on pre sleep cognitive arousal. If results of this study were significant, then 
this would indicate that the treatment is efficacious in the short term and further studies
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over a longer term should be carried out. Success in the long term may mean that this 
treatment could be included in existing treatment packages for insomnia.
Ethical Considerations
It is anticipated that no ethical considerations apply beyond those that are common to 
research where experimental variables are manipulated. Informed consent will be gained 
and will follow the guidelines proposed by COREC. It is anticipated that ethical approval 
will be gained from both Greater Glasgow and Argyll and Clyde Health Boards (where the 
primary investigator is employed), although no NHS patients will be solicited for, or 
included in, this study (see Appendices 3.2 and 3.3 for copies of ethical approval and 
research sponsorship).
Timescale
Ethical approval will be sought during June or July 2005. A minimum of 2 Actigraph 
watches will be available for sole use in this study. This will allow 2 participants to be 
recruited per week. This will mean that the minimum possible time for data collection is 14 
weeks. Allowing extra time for ‘slippage’, a conservative estimate for the data collection 
phase is 20 weeks, starting from the time ethical approval is received.
Health and Safety Issues
Where possible, a room on NHS property would be booked to be used to recruit and 
interview participants. Participants will not have previously been known to NHS
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Psychology services, referrals will not have been through the usual routes e.g. GP’s, and no 
previous risk assessment would be carried out on participants. However, all participants 
will have been vetted in some form by nature of their employment status within the NHS 
or University of Glasgow.
Proposed Costs/ Outlays
The proposed costs and outlays for this study are estimated in the attached proforma (see 
Appendix 3.4).
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Chapter 4
MAJOR RESEARCH PROJECT
Does a Pennebaker-like writing intervention reduce cognitive arousal 
and sleep onset latency in poor sleepers?
Major Research Project submitted in partial fulfilment of the requirement for the degree of 
Doctor of Clinical Psychology
Prepared in accordance with the guidelines for Behavioral Sleep Medicine (Appendix 4.1).
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Abstract
The present study considered the role of pre sleep cognitive arousal, inhibition and 
suppression in sleep onset difficulties. The Pennebaker writing task, which promotes 
emotional processing by asking people to write about their deepest thoughts, worries, and 
emotions, has proven effective in several areas of health, including oncology and Post 
Traumatic Stress Disorder. Here, the paradigms ability to reduce pre sleep cognitive 
arousal and sleep onset latency in people with insomnia was tested. 28 people with 
insomnia were randomised to three nights of Pennebaker writing or a control condition, 
following a one night baseline. The outcomes of change over baseline at day 4 in pre sleep 
cognitive arousal and sleep onset latency were compared between groups using analysis of 
variance normal linear models (ANOVA). Writing significantly reduced pre sleep 
cognitive arousal according to one out of two measures but did not significantly reduce 
sleep onset latency. The implications and possible explanations of the results are discussed.
Keywords: insomnia, cognitive arousal, emotional processing, writing intervention
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Primary or psychophysiologic insomnia (PI) involves difficulty initiating or maintaining 
sleep, in the absence of underlying medical or psychiatric causes (APA, 1994). PI is fairly 
common, with approximately 10% to 15% of the adult population (Mellinger et al, 1995; 
Ford & Kamerow, 1989) experiencing the disorder on a chronic basis. The disorder 
typically results in psychological distress, and can significantly impact social occupational 
and cognitive functioning (e.g. Mellinger et al, 1995; Ford & Kamerow, 1989; Gallup, 
1991).
The role of cognitive arousal is well established in sleep difficulties (Espie, 2002). Recent 
research indicates the pre sleep cognitive activity of people with insomnia (PWI) is 
excessive and uncontrollable, negatively toned, and covers a broad range of topics (e.g. 
Harvey, 2000). Wicklow and Espie (2000), for instance, directly sampled the pre sleep 
thoughts of PWI using tape recorders, and found that worry and thinking about sleep most 
strongly predicted delayed sleep onset. Importantly however, not all thinking amongst PWI 
is worrisome and negative (Wicklow & Espie, 2000). Furthermore, PWI perceive this 
activity as a major barrier to sleep (e.g. Espie et al, 1989; Harvey, 2000; Lichstein & 
Rosenthal, 1980). Lichstein and Rosenthal (1980) found that people with PI (PWI) are ten 
times more likely to quote cognitive arousal as central to their sleep disturbance compared 
to somatic arousal.
There is also evidence that such pre sleep cognitive arousal (PSCA) in PWI can be reduced 
by brief and novel interventions (e.g. Harvey & Payne, 2002; Carney & Waters, 2006). 
For example, Carney and Waters (2006) found that in a cohort of 33 undergraduate 
students, that engaging in “Constructive Worry” for five nights had a positive significant 
effect on PSCA according to the Pre Sleep Arousal Scale (Nicassio et al, 1985).
Evidence suggests that PWI inhibit or internalise their emotions (Kales et al, 1983; Kales 
& Kales, 1984). For example, Kales et al (1983) used the Minnesota Multiphasic 
Personality Inventory (MMPI) to assess personality patterns of 528 patients with chronic 
insomnia. The profiles of these patients were consistently characterised by, amongst other 
things, inhibition of emotions. Furthermore, Harvey (2001) found that thought suppression 
was employed more by PWI than good sleepers, when dealing with intrusive thoughts or 
worries at bedtime. Harvey’s (2002) cognitive model of the maintenance of PI draws on 
such evidence. Harvey suggests that unwanted PSCA amongst PWI may be a consequence 
of such inhibitive processes, causing the incomplete emotional processing of daily 
stressors. According to this hypothesis, ‘unfinished business from the day’ intrudes during 
the pre sleep period in PWI, fuelling PSCA and delaying sleep onset.
Other authors from the PI literature also acknowledge that bed time might possibly be the 
first time during the day that an individual has time to think about the day’s events, and 
worry and plan for the next day (Bootzin & Rider, 1997). Furthermore, Harvey’s 
explanation is commensurate with Rachman’s (1980) model of emotional processing. In 
this model, emotional processing is the method whereby emotional disturbances are 
absorbed, and subsequently decline, so that other behaviour can proceed without 
disruption. According to this model, suppressing emotional expression impedes emotional 
processing, and incomplete emotional processing can result in PI (Rachman, 1980).
Inducing PWI to write about thoughts and worries before they get to bed might therefore, 
in theory, improve sleep by facilitating emotional processing and ameliorating PSCA. One 
approach to achieve this is the Pennebaker writing task. The task asks people to write
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about their deepest thoughts, worries, and emotions for 15 to 20 minutes (e.g. Pennebaker 
& Beall, 1986; Pennebaker et al, 1988). Two meta analyses (Smyth, 1998; Frisina et al, 
2004) have found beneficial effects of the task with non clinical and clinical populations, 
(e.g. Post Traumatic Stress Disorder and oncology patients) on a range of physical and 
psychological outcomes, including sleep.
A recurring puzzle concerns how and why this paradigm works (Pennebaker, 2004; 
Bootzin, 1997). No single theory or theoretical perspective has convincingly explained its 
effectiveness (Pennebaker, 2004), although two theories predominate the literature. One is 
that writing about emotions reverses emotional inhibition and facilitates emotional 
processing. The second hypothesises that translating experiences into language by writing 
promotes organisation of problem descriptions into coherent stories, thereby facilitating 
cognitive changes that increase insight (Pennebaker, 1997). Despite this ambiguity, 
Bootzin (1997) has highlighted the potential utility of Pennebaker’s writing intervention as 
a component for treatment of mental health problems including PI, but emphasises the 
need for prior systematic research into its benefits for individual problem areas.
Despite extensive research on the Pennebaker paradigm, and converging evidence that 
PWI frequently experience PSCA (Harvey, 2000; Wicklow & Espie, 2000) which delays 
sleep onset (Lichstein & Rosenthal, 1980; Gross & Borkovec, 1982; Hall et al, 1996), 
surprisingly, only one study has specifically used the intervention in a population 
exclusively with sleeping difficulties. Harvey and Farrell (2003), in a recent pilot study, 
found that PWI who wrote about problems and worries prior to bed using the Pennebaker 
task, experienced shorter estimated SOL compared to PWI who did not.
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The Harvey & Farrell (2003) data are encouraging, and highlight the potential to improve 
PI with a simple intervention designed to facilitate processing of pre sleep cognitions and 
worries. Cognitive behaviour therapy for PI (CBTI) has a strong evidence base (Morin et 
al, 1999; Murtagh & Greenwood, 1995), but typically, includes no worry-specific 
cognitive components (Carney &Waters, 2006). Clarification of the efficacy of the 
Pennebaker task in treating PI may allow its inclusion in CBT for PI treatment packages.
However, several methodological limitations of Harvey and Farrell’s (2003) study 
preclude any definitive conclusions about the tasks clinical utility with PWI. Not least is 
the fact that the rationale given to the writing task group may have led to expect sleep 
improvement. PWI who took part were informed that previous research had showed 
benefits for sleep in writing down thoughts and concerns, and that this task would similarly 
help them organise and process their thoughts. Results may therefore reflect a placebo 
effect relating to demand expectations (Bootzin et al, 1976). Furthermore, Harvey and 
Farrell (2003) employed no objective SOL measure, and no baseline period was employed. 
The observed changes in sleep may therefore reflect an artefact of errors in subjective 
estimation, inter-subject variability or change to habitual bedtime/wakening unrelated to 
the experimental (Pennebaker) intervention. Finally, no measures were included to clearly 
delineate whether effects were indeed mediated by a reduction in PSCA.
The current study therefore aimed to replicate and extend this and other previous research, 
by applying the Pennebaker task to PWI. Drawing on the extant cognitive PI literature, 
and on studies of the Pennebaker writing task in health and, in particular, sleep, the 
hypothesis that a early evening writing task designed to facilitate processing of cognitions 
and worries would reduce (i) PSCA and (ii) SOL, was tested. Importantly, the
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methodological limitations inherent in the Harvey and Farrell pilot study outlined above, 
were directly addressed. In this respect, an objective measure of sleep was employed 
(actigraphy), PSCA was measured (Pre Sleep Arousal Scale; Nicassio et al, 1985), and 
counter demand instructions were given to participants (“do not expect any improvement 
to sleep”). It was hypothesised that, following a one night baseline, participants 
randomised to the experimental condition (Pennebaker writing task), would show reduced 
PSCA and SOL, compared to participants randomised to a control condition. Importantly, 
the work described here was not designed as a treatment study, rather as an experimental 
examination of the applicability of the paradigm to PI.
Method
Participants
Participants were recruited using a group email sent to university students and health 
service staff (c.f. Broomfield and Espie, 2003). Prior to inclusion, and in the absence of 
any psychometrically validated alternative, for inclusion participants were assessed by a 
locally developed semi structured clinical interview (see Appendix 4.2), and using 
standardised questionnaires. In this respect, participants also completed screening 
questionnaires assessing sleep (PI Severity Index [ISI] - Morin, 1993; Pittsburgh Sleep 
Quality Index [PSQI] - Buyesse et al, 1989) and mood (Beck Depression Inventory II 
[BDI-II] -  Beck et al, 1996). The ISI and PSQI are widely used to determine inclusion in 
PI studies (e.g. Broomfield & Espie, 2003; Harvey & Farrell, 2003; Carney & Waters, 
2006; Harvey & Payne, 2002; Marchetti et al, 2006).
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Respondents were included if they were aged between 16 and 65, and complained of 
clinically significant difficulties falling asleep which were the result of excessive PSCA 
(“experience persistent thoughts when trying to sleep”; “racing thoughts in bed that prevent 
falling asleep”). Following International Classification of Sleep Disorders (Second Edition) 
criteria for PI (American Sleep Disorder Association, 2005), clinically significant sleeping 
difficulties were defined as SOL >30 minutes on four plus nights per week for at least for 
4 weeks, with or without disruption to other sleep variables. In addition, participants scored 
> 5 on the PQSI and > 8 on the ISI, both recognised cut-off criteria for identifying clinical 
PI (Morin, 1993; Buyesse et al, 1989). Participants with sleep maintenance difficulties 
were included only if they reported concomitant initiation difficulties. Participants were 
excluded if they were receiving treatment for sleeping difficulties (either psychological 
and/or pharmacological) or were suffering from any co morbid sleep (apnoea, restless legs 
syndrome, etc), medical, or psychiatric condition known to influence sleep.
Thirty two participants were identified, all of whom met criteria for PI. Three failed to 
attend their initial meeting and one person withdrew during baseline, leaving twenty eight 
who completed the experiment. This sample size was adequate for power purposes, on the 
basis that a sample of 28 participants (14 per group) would have 80% power to 
successfully detect a difference between groups at p<0.05. Data for this calculation were 
extracted from the experimental and ‘sleep as usual’ conditions of the Harvey and Farrell 
study (2003).
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Design and Procedure
Participants who replied to the group email declaring an interest in the study were sent 
copies of the information sheet and consent form by email. Those who responded 
expressing a desire to participate were contacted by email or telephone (dependent on 
preference) to arrange an initial meeting. At the initial meeting, written informed consent 
was obtained (see Appendices 4.3 and 4.4) and participants were screened to identify 
whether they met inclusion criteria using the semi structured clinical interview.
Participants who met inclusion criteria were then blindly randomised to either the 
experimental task or the control condition by an independent person. Group allocation was 
determined using a random number generator.
Participants were then shown how to complete the sleep diary and how to use the actigraph 
watch. They were asked to button press the actiwatch once at lights out, and again on 
rising. Participants were also requested to limit their alcohol intake to a maximum of 4 
units and to carry on with their normal sleeping practices, while wearing their actigraph 
watch at all times (with the exception of during wet activities). As patients' expectations 
can influence response to other interventions (Espie & Lindsay, 1985; Broomfield & Espie, 
2003), and unlike Harvey and Farrell (2003), all participants were explicitly told not to 
expect any improvement in sleep during the experiment.
Participants were then given four envelopes marked days 1, 2, 3 and 4. Envelopes 
contained instructions for each day according to the relevant condition, as well all 
materials required for that day. Following Harvey and Farrell (2003), experimental nights
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were scheduled for weekday nights, to increase the likelihood that participants would have 
a regular sleeping routine and follow alcohol intake guidelines.
Participants’ sleep and PSCA was first monitored for a 1 day/night baseline period (day 1). 
Participants were then asked to follow the instructions described below, relevant to their 
group, for a further 3 days/nights (days 2 - 4 ) .  These timescales are typical of the 
Pennebaker literature (e.g. Pennebaker & Beall, 1986; Pennebaker et al, 1988), and in 
experimental studies manipulating novel interventions for PI (e.g. Harvey & Payne, 2002; 
Haynes et al, 1981; Harvey, 2003).
Following four nights, a final meeting with the researcher was convened. Adherence to 
protocol was assessed for all participants, alongside treatment credibility for the writing 
group only. Participants were thanked, debriefed and issued with the ‘Good Sleep Guide’, 
a leaflet describing cognitive behavioural PI advice for home practice (National Medical 
Advisory Committee, 1993).
Experimental Condition
Participants in the experimental condition were given written instructions based on those 
used by Harvey and Farrell (2003) and Pennebaker (1997; see Appendix 4.5). Participants 
were asked to “spend 20 minutes writing about any thoughts, concerns, or worries in the 
early evening (between 6pm and 8 pm )”. This time was chosen as it was thought that 
engaging in such a task nearer to bedtime might prove activating, and therefore too 
arousing to be effective (Harvey & Farrell, 2003; Espie & Lindsay, 1987). Participants 
were instructed to engage in the writing task outwith the bedroom, to ensure that worries 
they wrote about did not become associated with the bedroom environment (Bootzin,
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1972/ Participants could write about the same or different concerns during each writing 
session. As with Harvey and Farrell (2003), participants were not required to show the 
researchers their writings, to encourage honest and free expression.
Control Group
The control group were instructed to “complete two questionnaires about your worries 
between 6pm and 8pm” (c.f. Carney & Waters, 2006): the Penn State Worry
Questionnaire (PSWQ; Meyer et al, 1990) and the Worry Domains Questionnaire (WDQ; 
Tallis et al, 1992). These questionnaires were timed during piloting of the study to take 
approximately 15 to 20 minutes to complete. In addition, Carney and Waters (2006) found 
these to take on average approximately 15 minutes to complete. This ensured controls 
spent approximately the same amount of time focussed on their worries as the 
experimental group, but without the hypothesised facilitation of emotional processing as 
per the experimental task. Again, control participants were asked to complete the 
questionnaires outwith the bedroom environment (c.f. Bootzin 1972).
Measures
Sleep
For both groups, a daily sleep diary (Espie, 1991) was completed on rising for each study 
day. Sleep diaries are the gold standard measure of subjective sleep (Chesson et al, 2000). 
The diary data provided subjective measures of sleep onset latency (SOL) as well as data 
regarding alcohol intake.
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Additionally, wrist actigraphy (Actiwatch model AW2; Cambridge Neurotechnology Ltd) 
provided an objective estimate of SOL. Wrist actiwatches were worn at all times except 
during wet activities, and assess nocturnal movement levels. Movement at night is known 
to be a good predictor of wakefulness and lack of movement a good predictor of sleep 
(America Sleep Disorders Association, 1995; Mullaney et al, 1980). Several reviews 
(Lichstein et al, 2006; Littner et al, 2003; Sadeh et al, 1995; Mullaney et al, 1980) indicate 
actigraphy correlates highly with polysomnographic (PSG) data, particularly for sleep 
continuity variables e.g. sleep efficiency, and that it is considered a useful outcome 
measure in intervention studies using PWI.
Cognitive Arousal
The cognitive subscale of the Pre Sleep Arousal Scale (PSAS-C; Nicassio et al, 1985) 
contains 8 items examining symptoms of PSCA experienced at bedtime (e.g. racing mind; 
being distracted by sounds and noise in the environment; worry about falling asleep). 
PSAS-C was completed by all participants alongside the sleep diary, with respect to the 
previous evening. In addition, a 5 point Likert scale provided an additional measure of 
PSCA (see Appendix 4.6). This required participants to rate “How mentally alert you felt 
last night while you were trying to get to sleep” (anchor points 1 “not at all”, 5 
“extremely”) and has been used successfully in previous studies of PSCA (Robertson, 
Broomfield & Espie, submitted).
Emotional Processing in Writing Group
In the absence of a psychometrically validated alternative, the extent to which individuals 
emotionally processed the worries they wrote about was assessed using three Likert scales 
(“I worked through some upsetting issues”; “Writing helped me organise my thoughts”;
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“My thoughts/opinions have changed regarding the subject I wrote about”; anchor points 0 
“not at all”, 3 “a lot”). These were also completed in the morning along with the sleep 
diaries and measures of PSCA (see Appendix 4.7).
Adherence to Writing Task
Adherence to the writing instructions was monitored at the final meeting using a 
manipulation check akin to Harvey and Farrell’s (2003). Participants rated the content of 
their writing on a scale from -5 (about sad/anxiety related things) to +5 (about happy 
things). Participants also estimated how long they wrote for in general over the three days.
Writing Task Credibility and Utility
Treatment credibility and utility of the writing task was assessed using four questions 
based on Borkovec and Nau’s (1972) Therapy Evaluation Questionnaire. These assessed 
the perceived logic of, and confidence in, the writing intervention, participant willingness 
to repeat the intervention, and the perceived likelihood the intervention would help others. 
Three of these questions used a 6 point Likert scale (anchor points 0 “not at all”, 6 “very 
much”). The fourth question asked participants to respond “yes” or “no” to whether they 
would use the task again. These data were collected at the final meeting for the 
Pennebaker group.
Adherence to Study Protocol
Finally, all participants rated adherence to the study protocol, at the final meeting using a 6 
point Likert scale (c.f. Broomfield and Espie, 2003; “To what extent did you comply with 
the experimental instructions given to you during the study?”; anchor points 0 “not at all”,
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6 “very much”). The total number of nights each participant correctly followed the study 
protocol was also recorded.
Data Analysis
After checking the appropriateness of the data, a one way ANOVA model was employed 
using difference scores (Day 4 -  Day 1) on each of the dependent variables with the 
between participants factor of Condition (Pennebaker; Control). The independent variable 
was ‘Condition’. The dependent variables were PSCA (PSAS-C and alertness scale) and 
SOL (diary and actigraphy).
Results
Participant Characteristics
Table 1 presents the mean scores for participant characteristics overall, and by group. 
Overall mean age of the participants was 32.89 (SD = 13.96) and the overall ratio of 
females to males was 18:10. Groups were compared using a one way analyses of variance 
(ANOVA) or Chi-square (for gender). No significant differences were found on any of the 
variables reported (all p  > 0.10, NS; see Table 1).
Insert Table 1 about here
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Manipulation Checks and Adherence to Experimental Instructions
Participants reported correctly following experimental instructions on a mean of 3.96 
nights (SD = 0.19) out of four. Mean adherence rating was 5.96 (SD = 0.19; scale 0-6). 
This included pressing the Actiwatch, and completing the various study tasks. Only one 
participant reported anything other than maximum adherence on all days.
One way ANOVA compared adherence and task acceptability in both groups. No 
significant differences were found between the writing and control group in terms of extent 
of adherence (F [1, 26] = 1.00,/? = 0.327, NS), number of nights adhered (F [1, 26] = 1.00, 
p  = 0.327, NS) or acceptability/sensibility of tasks (F [1, 26] = 1.00, p  = 0.327, NS). 
Together, these analyses indicate no differences between the groups in terms of adherence 
to study protocol.
Thirteen of the 14 writing group participants complied with the recommended writing 
time, as per task instructions (15-20 minutes). Participants reported a mean rating o f -3.58 
(SD = 1.98) with regards to the content of their writing (scale -5 to +5; sad/anxiety related 
to happy). This indicates that participants in the writing group followed the writing 
instructions in that they wrote about worrisome or negative topics.
Credibility of Writing Task
Only one participant in the writing group indicated that they would not engage in the 
writing again to help their sleep. The mean scores for confidence in using the task in the
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future and recommending the task to a friend experiencing sleeping difficulties were 5.00 
(SD = 1.41) and 5.17 (SD = 1.40), respectively (scale 0-6). Participants thus found the task 
credible and of use.
Outcome Variables
Outcome data were first examined for kurtosis, skewness and homogeneity of variance and 
was considered suitable for parametric analysis (Field & Hole, 2003). In this respect, the 
primary outcome data (PSAS-C; alertness rating; SOL diary; SOL actigraphy) were 
considered normally distributed according to Kolmogoroc-Smimov Z tests of normal 
distribution {D (27) = 0.680, p  = 0.744, NS; D (27) = 1.019, p  = 0.250, NS; D (28) = 
0.876, p  = 0.426, NS; D (25) = 1.328,/? = 0.059, NS, respectively}. In addition, normal Q- 
Q plots were produced which supported these analyses.
The outcomes of change over baseline at day 4 in PSCA (PSAS-C and alertness scale) and 
SOL (diary and actigraphy) were compared between the two groups using normal linear 
models (one way ANOVA). Change score analyses were employed to account for the 
variability in participants’ scores at baseline. This method has been used successfully 
employed in both sleep and nonsleep related experimental studies (e.g. Roehrs et al, 1999; 
Carlson & Garland 2005; Gumley et al, 2003; Cohen-Zion et al, 2001), and was carried out 
both with and without adjustment for the mean of that variable at baseline. Baseline rates 
were covaried out using the same model described above (i.e. ANOVA), but imputing the 
baseline rate of the dependent variable as a covariate. Covarying the baseline rates of 
dependent variables out in this manner accounted for their effect on scope for 
improvement. As such, two separate one way ANOVAs both with a Between Factor of
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Group (Writing Task x Control) were carried out for each of the four dependent variables 
(PSAS-C, alertness, SOL diary, SOL actigraph); one ANOVA involved the initial change 
score, a second ANOVA involved the adjusted change score. Results of both are outlined 
below.
For each of these variables, Table 2 illustrates data for baseline and day 4, change over 
baseline, and the adjusted change figures after the baseline rates for the variables had been 
accounted for. Figures 1-4 indicate group baseline (dayl) and day 4 rates for each variable.
Insert Table 2 about here
Cognitive Arousal
Analysis of PSAS-C revealed a non significant main effect of Group (F [1, 25] = 0.963,p  
= 0.336, NS). The writing group did not show significantly greater reduction in PSCA on 
PSAS-C relative to controls. On analysis of alertness ratings, there was a significant main 
effect of Group (F  [1, 25] = 6.766, p  = 0.015). This confirmed the initial hypothesis in that 
the writing group showed a significantly greater decrease in PSCA according to alertness 
ratings relative to controls. This increase yielded a small effect size (ES = 0.21).
These findings for PSAS-C and alertness were confirmed after adjustment for baseline 
rates. For PSAS-C, the main effect of Group was again non significant (F [1, 24] = 0.380, 
p  = 0.543, NS). Whereas analysis of alertness ratings again revealed a significant main
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effect of Group (F [1, 24] = 7.20, p  = 0.013), indicating reduced PSCA on this measure 
amongst the writing group, relative to controls.
Insert Figures 1-4 about here
Sleep Onset Latency
Analysis of SOL diary data revealed a non significant main effect on Group (F [1, 26] = 
1.494, p  = 0.233, NS). The writing group did not show significantly greater reduction in 
SOL, relative to controls, according to diary data. Analysis of actigraphy data also revealed 
a non significant main effect on group (F [1, 23] = 1.058,/? = 0.314, NS). This confirmed 
the diary data in that the writing group did not show a significantly greater reduction in 
SOL relative to controls according to actigraphy data.
Once again, these findings were confirmed after adjustment for their rates at baseline. For 
SOL diary data, the main effect of Group was non significant (F [1, 25] = 0.265,/? = 0.611, 
NS). Again, the SOL actigraphy data revealed a non significant main effect on Group (F 
[1, 22] = 0.037,/? = 0.848, NS). Thus, these adjusted scores confirmed that results did not 
show a significant reduction in SOL relative to controls on either measure.
Emotional Processing in Writing Group
To coordinate with the primary analyses of PSCA and SOL, results from the emotional 
processing questionnaire for the last day of writing (day 4 overall) are reported in Table 3.
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As is evident, nine participants reported their writing to be ‘at least some benefit’ in 
helping them work through issues (N = 12), eleven thought that writing ‘helped them 
organise their thoughts to some degree’ (N = 12), and seven reported that ‘their thoughts 
had changed on the topic they wrote about at least to some extent’ (N = 12). Therefore, it 
seems the writers believed that the task had some effect on the organisation and emotional 
processing of their chosen concerns.
Insert Table 3 about here
Discussion
The current study tested the notion that a Pennebaker-like writing task would reduce 
PSCA and SOL in PWI. Supporting the initial hypotheses, the writing task significantly 
decreased PSCA according to participants’ self rating of alertness relative to the control 
condition. However, contrary to the initial hypotheses, the experimental manipulation did 
not reduce PSCA at bedtime on PSAS-C. Nor did it significantly reduce SOL on either 
subjective or objective estimates of sleep.
Adherence was high amongst the experimental participants, with respect to length and 
content of writing. Moroever, credibility ratings of the writing task indicated that 
generally, participants found the task of use to them. Participants reported high rates of 
confidence that the task would work for them in the future, and indicated a high possibility 
that they would recommend the writing task to a friend suffering from PI. Indeed, results
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from the writing task questionnaire indicated that more than half of the experimental group 
felt that it benefited them to use the writing task to work through issues, organise thoughts 
and change opinions. Furthermore, both groups were similar with regards to the 
acceptability of the experimental rational and adherence.
The observed decrease in PSCA on self-rated alertness, and the findings that participants 
reported this task to be of benefit, were observed however in the absence of any 
corresponding decrease in SOL. This might be because the present study was too brief for 
any decrease in PSCA to translate into change on SOL. Carney and Waters (2006) 
compared a “Constructive Worry” writing paradigm in PWI with a control task similar to 
the one used in this study over 5 days. “Constructive Worry” required participants to 
record worries they anticipated would keep them awake at night, and write down steps that 
could contribute to the resolution of the problem. They observed change on PSAS-C but 
did not find the proposed changes on all measures (e.g. State Trait Anxiety Inventory -  
State Version; Spielberger, 1983). And more pertinently, Carney and Waters (2006) 
considered their study of 5 nights duration “too brief to detect any meaningful change on 
sleep”, and suggested that a longer study would be required for change to be observed on 
SOL. In support of this, there is evidence from psychological treatment studies of CBTI 
which suggests that sleep changes are not immediate (Hauri, 1997; McCluskey et al, 1991; 
Morin et al 1999; Edinger et al, 2001).
The lack of parallel PSCA decrease amongst writers on PSAS-C might be explained by the 
fact that the two measures of PSCA tap into different processes. On closer examination, 
the alertness scale appears to measure general cognitive arousal whereas the PSAS-C is 
significantly correlated with anxiety and depression and is therefore considered to measure
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negatively toned activity (Nicassio et al, 1985). It is possible therefore, that the processing 
purported to accompany the writing task decreases alertness without necessarily affecting 
negatively toned cognitive activity. However, at present, there is no evidence to suggest 
that this is the case. Rather, it may be that given the number of data points observed for 
these respective measures, it was more difficult to statistically detect changes on the 
PSAS-C.
The differing results regarding SOL in this study to that of Harvey and Farrell (2003) may 
be explained in two ways. Firstly, a demand characteristic may account for the significant 
reduction in SOL which was observed following their writing task. In their study, groups 
completed a writing task similar to the current one, wrote about hobbies, or did not engage 
in writing. However, unlike here, the rationale given to both the problem and writing 
hobbies groups explicitly led participants to expect their tasks would benefit sleep. This 
may be why, although the problem writing group differed significantly from the control 
group, there was infact no significant difference between problem writers and the hobbies 
group. Therefore, the significant sleep findings in Harvey and Farrell’s (2003) study may 
not reflect a true improvement in SOL as a result of this task. Rather, they may reflect a 
‘placebo’ effect (Bootzin et al, 1976) which was controlled for in the present study. Taken 
along with the lack of effect on sleep in the present study, this could indicate that this task 
is of limited clinical utility.
Second, the discrepant results may also relate to differences between the respective 
samples and methodologies. The mean age in the current study was higher than that of 
Harvey and Farrell (2003). In this respect, the mean age of 32.89 (SD = 13.96) was found 
in the current study, compared with means of 23.7 (SD = 7.2), 21.9 (SD = 4.9), and 22.1
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(SD = 4.1), respectively for the three groups in Harvey and Farrell’s (2003) study. This is 
important. Thirty six years was the mean age of patients treated for PI in England between 
2002 and 2003 (Department of Health, 2003). Moreover, typically, the mean age of 
participants in studies of clinical PI is usually forty and above (see e.g. Espie et al, 2001; 
Lacks et al, 1983; Unger et al, 2004). Also, despite their inclusion criteria, approximately a 
quarter of Harvey and Farrell’s (2003) sample did not even meet the criteria for clinical PI, 
scoring below 5 on PSQI. This is interesting. Even in PI studies employing analogue non­
patient samples, mean PSQI scores often exceeds 7 (e.g. Marchetti et al, 2006; Broomfield 
& Espie, 2003; Nelson & Harvey, 2003). Finally, there may also be a difference in the 
distressing nature of topics written about. Mean affect ratings for writing content were 
higher in the current study than in the Harvey study (M = -3.58, SD = 1.98; and M =-1.8, 
SD = 2.0, respectively).
Perhaps then, the sample studied here were more akin to a clinical population than were the 
Harvey and Farrell (2003) cohort. And by implication, participants who experience 
complex sleep problems may be less likely to display sleep change over this short period. 
It may also be possible that the Pennebaker writing paradigm is less helpful for clinical 
populations of PWI, or those suffering from more severe difficulties. This latter 
hypothesis would be supported by a recent meta analysis by Frisina et al (2004). They 
recognized the effect of the Pennebaker writing task on sleep, but found that the mean 
weighted effect size of clinical populations was modest (d = 0.19) in comparison to that 
found in a meta analysis of Pennebaker writing tasks for healthy people (d = 0.47; Smyth, 
1998). Further research comparing response of an analogue and true clinical PI samples 
will be necessary to clarify this.
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Taking the above factors into account, the limitations of the present study should be borne 
in mind when interpreting the results. Although the number of writing sessions in 
Pennebaker tasks appears unrelated to improvement (Smyth, 1998), it has been argued that 
lengthening the time course over which the writing task is spaced, may be beneficial 
(Smyth, 1998). Notably, the present study closely followed the original protocol used by 
many authors (e.g. Sloan et al, 2005; Sloan and Marx, 2004; Norman et al, 2004; Kloss et 
al, 2002; Zakowski et al, 2004) in that the writing task took place over three consecutive 
days. Nevertheless, it may be prudent in future research to conduct a lengthier study (e.g. 
21 nights) with more widely spaced sessions (e.g. 3 writing sessions at weekly intervals) to 
maximise any effects.
The current study, given its application to PWI, followed Harvey and Farrell’s (2003) 
protocol by only measuring the immediate effects of the task. However, some researchers 
employing the Pennebaker task in other fields have tended not to consider immediate 
effects, concentrating instead on longer term impact. For example, Zakowski et al (2004) 
examined the effects of this paradigm on 104 patients with cancer and found that the task 
buffered the effects of social constraint on stress at 6 month follow up. Therefore, it may 
be that any benefit of this task with respect to PWI is typically not immediate. Broderick 
et al (2005) found no significant effect on fatigue and psychological wellbeing amongst 
fibromyalgia patients immediately post writing, but did find a significant improvement in 
psychological wellbeing at 4 months follow up.
However, this hypothesis does not sit easily with the pattern of results obtained here on 
PSCA, the fact that participants in this study mostly reported the task helpful, and indeed 
the Harvey and Farrell’s (2003) results. Perhaps the most parsimonious explanation to
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reconcile these findings may be that the demand characteristics of Harvey and Farrell 
(2003) served to accelerate or magnify any true benefit of the task. As such, future 
Pennebaker studies of PWI should assess outcome some time after completing the 
paradigm, as well as immediately, to fully capture any effects.
The present study also drew on the premise that PWI often experience uncontrollable 
cognitive arousal at night (Harvey, 2000). Accordingly, participants were included only if 
they complained of excessive PSCA. However, no attempt was made to select participants 
who specifically experienced negatively toned pre sleep cognitions. This may have 
minimised any likely effects. Indeed, some participants’ reported to the researcher that 
their pre sleep cognitive activity was not necessarily negatively toned. This would be 
consistent with studies of PWI directly sampling thinking patterns at night. Wicklow & 
Espie (2000) have shown, for example, that not all thinking amongst PWI is worrisome 
and negative.
The Pennebaker task has shown success in physical health worries (Broderick et al, 2005; 
Rosenberg et al, 2002) and trauma (Schoutrop et al, 2002). It has also shown greater 
effects in participants who display higher levels of catastrophisation (Norman et al, 2004). 
Therefore, the paradigm may be more beneficial to PWI who specifically report high rates 
of worrying and negatively toned PSCA rather than those who simply complain of general 
PSCA at night. Furthermore, given that effects of this task are not equivalent across all 
areas of application (Smyth, 1998; Frisina et al, 2004), it is entirely possible that this task 
is more effective on some ‘types’ of problems, worries or concerns than others. The effect 
of these issues on the current study, however, may be limited. Harvey and Farrell (2003) 
did not select on this criteria and yet still found significant effects. Selecting participants
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on this more specific aspect of pre sleep cognition or comparing PWI who display high 
and low levels of negatively toned PSCA might be a next step in examining this paradigm.
Consistent with this failure to select on negatively toned PSCA, the PSAS-C ratings 
obtained in the current study were not as high as expected. For example, Nicassio et al 
(1985) obtained mean ratings of 25.5 in their sample 30 of PWI. In addition, Carney and 
Waters (2006) who produced significant effects in their study on PSAS-C, reported higher 
mean baseline rates for their sample than was reported here. They reported mean PSAS-C 
scores in their control and “Constructive Worry” groups of 30.97 (SD = 5.58) and 31.72 
(SD = 5.46), respectively, compared to 19.86 (SD = 6.22) and 21.92 (SD = 6.59) in the 
control and writing groups here. Thus, there may have been a greater initial scope for 
improvement than in this study. However, it should be noted that they do not report 
selecting on this and, once again, failing to select on this criteria did not have an adverse 
effect on Harvey and Farrell’s (2003) results. Future research will be required to clarify 
this.
In summary, as hypothesised, PSCA according to self rated mental alertness decreased, but 
PSAS-C scores remained unchanged following a Pennebaker writing task. However, the 
present study failed to support Harvey and Farrell’s (2003) results regarding SOL in that 
no significant change was found on objective or subjective SOL measures. Several factors 
may account for these results. Notably, the study period may have been too brief to detect 
sleep changes (c.f. Carney & Waters, 2006). Alternatively, demand characteristics from 
the Harvey and Farrell (2003) paper may have accelerated or aided sleep effects in their 
study. Along with these issues, limitations such as the selection of participants may also
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have precluded a more positive finding. Further research using a longer follow up should 
help better clarify the potential efficacy of this paradigm with PWI.
I l l
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Table 1. Mean scores and standard deviations for participant characteristics and estimates 
of sleep onset latency at intake.
Writing Group Controls Total
Sex (F: M ratio) 8:6 10:4 18:10
Age 33.29(12.32) 32.50 (15.89) 32.89(13.96)
Usual SOL 75.00 (44.03) 95.36 (61.16) 85.18 (53.31)
PSQI 9.93 (2.87) 11.00 (2.60) 10.46 (2.74)
ISI 14.71 (3.97) 15.29 (4.21) 15.00 (4.03)
BDI 7.07 (7.14) 10.21 (7.13) 8.64 (7.18)
Standard deviation in parenthesis.
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Table 3. Descriptive results of the writing questionnaire for day 4
Question Very much To some 
extent
Not at all
I worked through some upsetting issues 1 8 3
Writing helped me organise my thoughts 4 7 1
My thoughts/opinions have changed 
regarding the subject I wrote about
1 6 5
125
Figure 1. Writing and Control PSCA - Day 1 and Day 4 Alertness Scores
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Figure 3. Writing and Control SOL - Day 1 and Day 4 Diary
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Figure 4. Writing and Control SOL - Day 1 and Day 4 Actigraphy
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Chapter 5
SINGLE CASE RESEARCH STUDY
Challenging behaviour or PTSD? Using single case methodology to 
inform psychological formulation in a woman with a learning disability.
Single Case Research Study submitted in partial fulfilment of the requirement for the 
degree of Doctor of Clinical Psychology
Prepared in accordance with the guidelines for Journal of Intellectual Disability Research 
(Appendix 1 - bound separately in Part Two).
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ABSTRACT
Background
Challenging behaviour ranges widely in topography and underlying processes. However, 
behaviour which others describe as ‘challenging’ may also be an atypical presentation of a 
mental health problem. Thus, behavioural function cannot be clearly determined from 
topography. The present study used an experimental functional analysis to assess the 
accuracy of two hypotheses of screaming and arm flapping in a severely learning disabled 
woman while travelling by car.
Method
An ABAC within series reversal design was employed to test whether screaming and arm 
flapping was: an atypical presentation (or secondary feature) of a traumatic reaction to 
being in the car; or challenging behaviour as a result of frustration at the car stopping or 
slowing down.
Results
Rates of screaming were higher when the car was stopped compared to baseline. No such 
elevated rates were found when the car was moving. A similar result was found for arm 
flapping although data were somewhat more equivocal.
Conclusions
The behaviour appeared to result from frustration at being delayed in obtaining a desired 
outcome. Results informed the psychological formulation of these difficulties. Subsequent 
management guidelines were developed to reduce this behaviour.
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APPENDICES FOR CHAPTERS 1-4
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from the printers on the penultimate Thursday o f  the month 
prior to the month o f  publication.
Submitting to Clinical Psychology
•  Articles o f  1000— 2000 words are w elcom ed. 
Send two hard cop ies o f  your contribution.
•  When sending copy, make sure it is double spaced, 
in a reasonably sized font and that all pages are 
numbered.
• G ive a 40-w ord summary at the beginning o f  the 
paper.
• Contributors are asked to use language which is 
psychologically  descriptive rather than medical 
and to avoid using devaluing term inology; i.e. 
avoid clustering term inology like 'the elderly' or 
m edical jargon like 'person with schizophrenia'. If  
you find you rself using quotation marks around 
words o f  dubious m eaning, please use a different 
word.
• Articles submitted to Clinical P sychology w ill be 
sent to members o f  the Editorial C ollective for
refereeing. They w ill then com m unicate directly 
with authors.
•  We reserve the right to shorten, amend and hold  
back copy if  needed.
•  Include a word count at the end (including refer­
ences).
•  Spell out all acronym s the first time they appear.
•  Include the first names o f  all authors and give  
their em ployers, and remember to g ive a full 
postal address for correspondence.
•  Give references in Clinical Psychology style, and 
i f  a reference is cited in the text make sure it is in 
the list at the end.
•  Don't include tables and figures unless they save 
space or add to the article.
•  Ask readers to request a copy o f  your question­
naire from you rather than include the w hole o f  it 
in the article.
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Appendix 1.2
P sy ch osocia l E ducation on S ch izo p h ren ia /P sy ch o s is  
F or peop le  w ith  a d ia g n o sis .o f . S ch izop h ren ia  and th e ir  c a r e r s  
E valuation Form
1 . How help fu l did you fin d  ea ch  o f  th e  e ig h t se ss io n s:-
V ery  H elpful Q u ite  H elpfu l N o t  H elp fu l1 N /A
S e ss io n  1 -  In tro d u ctio n , ou tline o f  se s s io n s . ■ .v  -
\
S e ss io n  2  -  W hat is Sch izoph ren ia?
v--; ' .■ •- ■ - ■; *’ •'"i
S e ss io n  3 -  Sym ptom s o f  S ch izop h ren ia
. . . • .• • ! *
S e ss io n  4  -  M ed ication  issu e s  A
S e ss io n  5  -  S tr e s s /R e la x a tio n
S e ss io n  6  -  Problem  solving
S e ss io n  7  -  R elapse p reven tion
S e ss io n  8  -  O ngoing to p ic s /ev a lu a tio n
2 . I f  you w ere  unable to  a t te n d  fo r  any o f  th e  se ss io n s , can you b r ie fly  in d ica te  why?
3 , W h at a sp e c t  o f  th e  group did you find  m ost helpful?
4 .  W h at d id you fin d  le a s t  helpful?
5 .  I s  th e r e  any to p ic s  t h a t  you would have included or sp en t m ore tim e  on?
132
6 . Have you made any positive life sty le  changes since attending th e  group?
□YES  j NO
I f  yes please indicate below: -
Having .greater understanding o f  condition
. Feeling; more able to  control symptoms ian<i-.manage relapse. : : <?
Feeling more able to discuss d ifficu lties with fam ily/friends: :; v - \
Feeling more able to discuss, a sp ects  o fc a r e  with health/social care
Professionals e,g. consultant psychiatrist
Using relaxation techniques
Using problem solving techniques
M eeting other people in similar situations
Improving relationship between person with diagnosis and carer  
Attending group
O
□
7 . Do you fe e l it was beneficial to  a ttend  the group together (person and carer)?  
YES □  NO □  DON’T KNOW
8. Would it have been more useful to  attend a group on your own?
YES NO DON'T KNOW
Comment
9 . Did you find th e  handouts useful? 
YES NO | |  Please explain
10. Do you still r e fer  to  th e  handouts? 
YES 1 I NO □ Please explain
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1 1 . Would you b e  in terested  in attending a se lf-h e lp  group or carers' forum?□YES NO
1 2 . Did you think th e  length o f  each  sess io n  was?
adequatetoo  iong f  □ to o  sh o rt
1 3 , W as th e  tripe o f  th e  group su itab le?  
YES |  I I N O
'141 Was the location of the group suitable?
* l - '
YES '• N O
P lease explain
4jj:
-
Please explain
1 5 . P lease use  th is  sp ace  to  ind icate any su ggestion s or com ments th a t may improve 
th e  group.
Thank you fo r  your co -o p era tio n .
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Clinical Psychology Review 
Guide for Authors
SUBMISSION REQUIREMENTS: Authors should submit their articles electronically 
via the Elsevier Editorial System (EES) page of this journal (http://ees.elsevier.com/cpr). 
The system automatically converts source files to a single Adobe Acrobat PDF version 
of the article, which is used in the peer-review process. Please note that even though 
manuscript source files are converted to PDF at submission for the review process, these 
source files are needed for further processing after acceptance. All correspondence, 
including notification of the Editor's decision and requests for revision, takes place by e- 
mail and via the Author's homepage, removing the need for a hard-copy paper trail. 
Questions about the appropriateness of a manuscript should be directed (prior to 
submission) to the Editorial Office, details at URL above. Papers should not exceed 50 
pages (including references).
Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract or as part of a published lecture or academic 
thesis), that it is not under consideration for publication elsewhere, that its publication is 
approved by all authors and tacitly or explicitly by the responsible authorities where the 
work was carried out, and that, if accepted, it will not be published elsewhere in the same 
form, in English or in any other language, without the written consent of the Publisher.
FORMAT: We accept most wordprocessing formats, but Word, WordPerfect or LaTeX 
are preferred. Always keep a backup copy of the electronic file for reference and safety. 
Save your files using the default extension of the program used.
Please provide the following data on the title page (in the order given).
Title. Concise and informative. Titles are often used in information-retrieval systems. 
Avoid abbreviations and formulae where possible.
Author names and affiliations. Where the family name may be ambiguous (e.g., a double 
name), please indicate this clearly. Present the authors' affiliation addresses (where the 
actual work was done) below the names. Indicate all affiliations with a lower-case 
superscript letter immediately after the author's name and in front of the appropriate 
address. Provide the full postal address of each affiliation, including the country name, 
and, if available, the e-mail address of each author.
Corresponding author. Clearly indicate who is willing to handle correspondence at all 
stages of refereeing and publication, also post-publication. Ensure that telephone and 
fax numbers (with country and area code) are provided in addition to the e-mail 
address and the complete postal address.
Present/permanent address. If an author has moved since the work described in the 
article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') 
may be indicated as a footnote to that author's name. The address at which the author 
actually did the work must be retained as the main, affiliation address. Superscript 
Arabic numerals are used for such footnotes.
Abstract. A concise and factual abstract is required (not exceeding 200 words). This
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should be typed on a separate page following the title page. The abstract should state 
briefly the purpose of the research, the principal results and major conclusions. An 
abstract is often presented separate from the article, so it must be able to stand alone. 
References should therefore be avoided, but if essential, they must be cited in full, 
without reference to the reference list.
STYLE AND REFERENCES: Manuscripts should be carefully prepared using the 
Publication Manual of the American Psychological Association, 5th ed., 1994, for style. 
The reference section must be double spaced, and all works cited must be listed. Please 
note that journal names are not to be abbreviated.
Reference Style for Journals: Cook, J. M., Orvaschel, H., Simco, E., Hersen, M., and 
Joiner, Jr., T. E. (2004). A test of the tripartite model of depression and anxiety in older 
adult psychiatric outpatients, Psychology and Aging, 19, 444-45.
For Books: Hersen, M. (Ed.). (2005). Comprehensive handbook of behavioral 
assessment (2 Volumes). New York: Academic Press (Elsevier Scientific).
TABLES AND FIGURES: Present these, in order, at the end of the article. High- 
resolution graphics files must always be provided separate from the main text file (see 
http://ees.elsevier.com/cpr for full instructions, including other supplementary files such 
as high-resolution images, movies, animation sequences, background datasets, sound 
clips and more).
PAGE PROOFS AND OFFPRINTS: When your manuscript is received by the 
Publisher it is considered to be in its final form. Proofs are not to be regarded as 'drafts'. 
One set of page proofs will be sent to the corresponding author, to be checked for 
typesetting/editing. No changes in, or additions to, the accepted (and subsequently 
edited) manuscript will be allowed at this stage. Proofreading is solely the authors' 
responsibility.
The Publisher reserves the right to proceed with publication if corrections are not 
communicated. Please return corrections within 3 days of receipt of the proofs. Should 
there be no corrections, please confirm this.
COPYRIGHT: Upon acceptance of an article, authors will be asked to transfer 
copyright (for more information on copyright, see http://authors.elsevier.com). This 
transfer will ensure the widest possible dissemination of information. A letter will be 
sent to the corresponding author confirming receipt of the manuscript. A form facilitating 
transfer of copyright will be provided.
If excerpts from other copyrighted works are included, the author(s) must obtain written 
permission from the copyright owners and credit the source(s) in the article. Elsevier has 
forms for use by authors in these cases available at www.elsevier.com/locate/permissions 
phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com
NIH voluntary posting policy US National Institutes of Health (NIH) voluntary posting 
(" Public Access") policy Elsevier facilitates author response to the NIH voluntary 
posting request (referred to as the NIH "Public Access Policy", see 
http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's 
manuscript directly to PubMed Central on request from the author, 12 months after 
formal publication. Upon notification from Elsevier of acceptance, we will ask you to 
confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com) that your work 
has received NIH funding and that you intend to respond to the NIH policy request,
136
along with your NIH award number to facilitate processing. Upon such confirmation, 
Elsevier will submit to PubMed Central on your behalf a version of your manuscript that 
will include peer-review comments, for posting 12 months after formal publication. This 
will ensure that you will have responded fully to the NIH request policy. There will be 
no need for you to post your manuscript directly with PubMed Central, and any such 
posting is prohibited.
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Appendix 3.1
Guidelines for Submission of Major Research Project Proposal
This can be written in the form of an application to a Local Research Ethics Committee 
and be presented, in full, in the final Research Portfolio. A copy of the letter(s) of ethical 
approval received from the LREC must also be included in the Research Portfolio. In 
circumstances where the completed project deviated from the original approved plan, the 
trainee must insert a clear explanation of these changes. Any further correspondence with 
the LREC, which relates to such changes must also be appended. The Major Research 
Project Proposal should include the following headings.
• Full title of project
• Summary of Project
• Introduction
• Aims and hypotheses 
Aims
Hypotheses
• Plan of Investigation 
Participants 
Recruitment 
Measures
Design and Procedures 
Settings and Equipment 
Power Calculation 
Data Analysis
• Practical Applications
• Timescale
• Ethical Approval
• References
W EST OF SC O T L A N D  /  U N IV E R SIT Y  OF G LA SG O W  DOCTORATE IN CLINICAL  
PSY C H O LO G Y  CO URSE H A N D B O O K  APRIL 1003
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Appendix 3.2
Prim ary  C are Division
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow G 12 OXH 
Tel: 0141 211 3600 
w w w .nhsgg.org.uk
NHS
Greater
Glasgow
Ms P Mooney Date 17 August 2005
Trainee Clinical Psychologist Your Ref
Department of Psychological Medicine, Our Ref
Gartnaval Royal Hospital
1055 Great Western Road Direct line 0141 211 3824
Glasgow Fax 0141 211 3814
G12 0XH E-mail anne.mcmahon(5>aartnavel.
glacomen.scot.nhs.uk
Dear Ms Mooney
F u l l  t i t l e  o f  s t u d y :  D o e s  a  P e n n e b a k e r - l i k e  w r i t i n g  i n t e r v e n t i o n  r e d u c e
c o g n i t i v e  a r o u s a l  a n d  s l e e p  o n s e t  l a t e n c y  i n  p o o r  
s l e e p e r s ?
R E C  r e f e r e n c e  n u m b e r :  0 5 / S 0 7 0 1 / 8 1
Thank you for your letter of 27 July 2005, responding to the Committee's request for further 
information on the above research and submitting revised documentation]
The further information was considered at the meeting of the Committee held on 11 August 
2005. A list of the members who were present at the meeting is attached.
C o n f i r m a t i o n  o f  e t h i c a l  o p i n i o n
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised.
The favourable opinion applies to the research sites listed on the attached form. 
C o n d i t i o n s  o f  a p p r o v a l
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully.
A p p r o v e d  d o c u m e n t s
The final list of documents reviewed and approved by the Committee is as follows:
Document Version Date
Application 26 June 2005
Investigator CV 26 June 2005
Protocol 26 June 2005
Protocol two 27 July 2005
Peer Review 26 June 2005
Compensation Arrangements 26 June 2005
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Copy of Questionnaire two 27 July 2005
Copy of Questionnaire 26 June 2005
Copy of Questionnaire Non-
Valid.Questi
onnaire
26 June 2005
Copies of Advertisements 26 June 2005
Letters of Invitation to Participants 26 June 2005
Participant Information Sheet 26 June 2005
Participant Information Sheet two 27 July 2005
Participant Consent Form two 28 July 2005
Participant Consent Form two -
researcher
27 July 2005
Participant Consent Form 26 June 2005
Response to Request for Further Information 27 July 2005
Management approval
The study should not commence at any NHS site until the local Principal Investigator has 
obtained final management approval from the R&D Department for the relevant NHS care 
organisation.
Membership of the Committee
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet.
Notification of other bodies
The Committee Administrator will notify the research sponsor that the study has a favourable 
ethical opinion.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
05/S0701/81______________Please quote this number on all correspondence
With the Committee’s best wishes for the success of this project, 
Yours sincerely
A W McMahon
Research Ethics Co-ordinator (Manager) on behalf of Dr Paul Fleming. Chair
Email: Anne.McMahon@gartnavel.glacomen.scot.nhs.uk 
Enclosures:
Attendance at Committee meeting on 11 August 2005 
Standard approval conditions 
Site approval form (SF1)
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Appendix 3.3
P r i m a r y  C a r e  D i v i s i o n Research & Development Directorate NHS
Gartnavel Royal Hospital 
1055 Great W estern Road
Glasgow G12 OXH 
Tel: 0141 211 3600 
w w w .nbsgg.org.uk
Greater
Glasgow
Ms P Mooney
Trainee Clinical Psychologist 
Department of Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow 
G12OXH
Date 27 Septem ber 2005
Your R ef
Our R ef BR/AW /approve
Direct Line 0141 2113661 
Fax 0141 211 3814
Email annette.w att@
gartnavel.glacom en.scot.nhs.uk
Dear Ms Mooney
Project Reference Number: 05CP14
Project Title: Does a Pennebaker-like writing intervention reduce cognitive arousal 
and sleep onset latency in poor sleepers?
Thank you for completing the Research & Development (R&D) Management Approval Application for the 
above study. I am pleased to inform you that R&D management approval has been granted by Greater 
Glasgow Primary Care Division subject to the following requirements:
• You should notify me of any changes to the original submission and send regular, brief, interim 
reports including recruitment numbers where applicable.
• Your research must be conducted in accordance with the National Research Governance standards, 
(see CSO website: www. show, scot, nhs. uk/cso )
Local Research Governance monitoring requirements are presently being developed. This may 
involve audit of your research at some time in the future.
• You must comply with any regulations regarding data handling (Data Protection Act).
• Brief details of your study will be entered on the National Research Register (NRR). You will be
notified prior to the next submission date and asked to check the details being submitted.
• A final report, with an abstract which can be disseminated widely within the NHS, should be
submitted when the project has been completed.
Do not hesitate to contact the R & D  office if you need any assistance.
Thank you again for your co-operation.
Yours sincerely
Brian Rae 
Research Manager
DI6II81
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Appendix 3.4
RESEARCH EQUIPMENT, CONSUMABLES AND EXPENSES
Trainee ...Patricia Mooney..........................................................................................................
Year of C ou rse 2nd............................................  Intake Year... 2003...................
Please complete the list below to the best o f  your ability:
Item Amount Required Approximate Cost
Plain Paper / Headed paper / 
envelopes
120 sheets headed paper 
500 sheets plain paper 
100 envelopes
Postage
100 second class stamps
Photocopying
500 (using paper above)
Acetates
N/A
Equipment
Miscellaneous:
Travel costs: 
Follow-up costs 
Phone calls 
Software
Computing equipment
480 miles travel (20 x 
journeys to Gartnaval 
Hospital from base)
Possible sou rces....................................................................................
Supervisor’s S ignature........................................................... Date
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Appendix 4.1
Behavioral Sleep Medicine - Instructions to Contributors
The editorial scope of Behavioral Sleep Medicine is given above. In brief, the journal 
publishes original research on the application of behavioral/cognitive science to the study 
of normal and disordered sleep. Submission of manuscripts presumes that the work has not 
been previously published in whole or in substance and is not simultaneously being 
considered for publication by another journal.
Manuscripts should be prepared in accordance with the Publication Manual of the 
American Psychological Association (5th edition). The manual sets forth guidelines for 
referencing, preparation of abstracts (maximum 120 words), bias-free language, spacing 
(double-spaced throughout), margins (1 inch, 2.54 cm, on four sides), formatting tables and 
figures, etc. To briefly summarize APA format for references, sources are cited in the text 
by author and year (e.g., Loomis, Harvey, & Hobart, 1937), and the reference list is 
arranged alphabetically. Examples of reference format for articles, chapters, and books are 
as follows.
Loomis, A. L., Harvey, E. N., & Hobart, G. A., III. (1937). Cerebral states during sleep, as 
studied by human brain potentials. Journal of Experimental Psychology, 21, 127-144.
Webb, W. B. (1970). Individual differences in sleep length. In E. Hartmann (Ed.), Sleep 
and dreaming (pp. 44-47). Boston: Little, Brown and Company.
Kleitman, N. (1939). Sleep and wakefulness. Chicago: University of Chicago Press.
Submit manuscripts to the Editor, Kenneth L. Lichstein, Sleep Research Project, 
Department of Psychology, The University of Alabama, Box 870348, Tuscaloosa, AL 
35487-0348. The copies should be complete with all tables and figures. Do not send 
original figures until the manuscript is accepted for publication. The submission should be 
accompanied by a cover letter requesting review and providing the address, phone, fax, and 
email of the corresponding author. The cover letter must also include the statement that 
research participants were treated in compliance with the ethical standards of one's 
discipline.
Submit two paper copies and an electronic copy of the manuscript. Submit a paper copy 
and an electronic copy of the cover letter as well. Electronic copies should be saved either 
as Adobe PDF files or in rich text format (rtf). Send electronic copies as email attachments 
to lichstein@ua.edu.
If the first author is 5 years or less post Ph.D. (or post residency for physicians) and wishes 
to be considered for the Early Career Distinguished Research Award, this should be stated 
in the cover letter (see announcement below).
Early Career Distinguished Research Award: The editorial leadership of BSM periodically 
encounters a particularly outstanding article from an early career investigator. Such articles 
are characterized by a level of methodological maturity and importance of findings more 
commonly associated with accomplished senior scientists. BSM will honor research that 
satisfies these standards with the Early Career Distinguished Research Award. The award
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comprises featured recognition in the journal and invited commentary by a distinguished 
scholar on the merits of the research. This award reflects the Journal's interest in honoring 
outstanding early career scientists, encouraging high quality research, and elevating the 
visibility of particularly important research for the readership. To be eligible, the first 
author must be 5 years or less post Ph.D. (or post residency for physicians) at the time of 
submission and should indicate in the submission cover letter that he/she wishes to be 
considered for this award.
The editorial scope of Behavioral Sleep Medicine is given above. In brief, the journal 
publishes original research on the application of behavioral/cognitive science to the study 
of normal and disordered sleep. Submission of manuscripts presumes that the work has not 
been previously
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Appendix 4.2
University of Glasgow Sleep Research Group 
Sleep Clinic Screening Form
ID Date:
Age:
Marital status: married: single: divorced: widowed 
Occupation:
Does this involve working nightshifts?
Retired: Yes: No 
Gender: Male/Female
1. How long have you had your sleep problem (number of years/months)?
i) Did this start before you were 10 years old?
ii) If yes to i), was there any identifiable precipitant to this?
iii) If yes to i) have your experience of sleeping difficulties been persistent since 
this time?
2. How many nights per week do you have difficulties sleeping?
3. How much sleep do you get on an average night?
4. Do you have difficulty falling asleep at night?
5. On average, how long (hours/minutes) does it take you to fall asleep each night?
6. Do you have difficulty staying asleep?
7. On average, how long in total (hours/minutes) are you usually awake at night (after you
have been asleep for the first time)?
8. Are you ever awake all night (not intentionally)?
If yes, how often?
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After such nights, do you nap the next day?
9. Occasionally, do you find that you get what you would consider a ‘normal’ night’s sleep?
If yes, how often?
10. On average, what time do you wake up in the morning?
11. On average, how long (hours/minutes) do you wake before you are required to?
12. How would you rate the quality of your sleep
Very good Fairly good Fairly bad Very bad
13. Other than difficulties in sleeping, is there anything that prevents you getting as much sleep 
as you would like e.g. having a young child, a partner who snores?
14. Do you experience any of the following in the day time due to your sleep problem?
Fatigue/malaise Yes/no
Attention, concentration, or memory impairment Yes/no
Social/vocational dysfunction or poor school performance Yes/no
Mood disturbance/irritability Yes/no
Daytime sleepiness Yes/no
Motivation/energy/initiative reduction Yes/no
Proneness for errors/accidents at work or while driving Yes/no
Tension, headaches and/or Gl symptoms in response to sleep loss
Yes/no
Concerns or worries about sleep Yes/no
15. Do you feel that you spend a disproportionate amount of time thinking and worrying about
your sleep? Yes/no
16. Do you have difficulty falling asleep in bed at the desired bedtime or during planned naps, 
but fall asleep with relative ease during monotonous activities e.g. watching TV or reading 
when not intending to sleep?
Yes/no
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17. Do you find that you sleep better away from home than at home?
Yes/no
18. Do you experience persistent thoughts in bed when trying to sleep that seem to come out
of the blue?
Yes/no
19. Do you experience ‘racing’ thoughts in bed that prevent you falling asleep as they are
impossible to control?
Yes/no
20. Do you find it almost impossible to relax enough in order to fall asleep at bedtime?
Yes/no
21. Does pain or physical discomfort interrupt your sleep at night?
Yes/no
If yes, does taking pain medication help this? Yes/no
21. Do you think that pain is the main cause of your sleeping problem?
Yes/no
22. Do any other physical health problems interrupt your sleep at night?
Please give details.
23. Have you suffered from any physical health problems in the past that have disrupted you
sleep?
Yes/No
24. When did your current sleeping difficulties occur in relation to these physical health 
problems?
25. Have you felt particularly ‘down’ or ‘sad’ or ‘empty’ about things in the past two weeks?
□ Never □ Sometimes □ Usually □ Always
26. Does your doctor know about this?
27. Are these low feelings a change from what is normal for you?
28. When did these feelings start?
29. In the past two weeks :
Have you lost pleasure in your usual activities? Yes/No
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Has your appetite changed? Yes/No
Have you lost or gained weight? Yes/No
Have you lacked energy? Yes/No
Have you felt agitated? Yes/No
Have you felt slowed down? Yes/No
Have you thought about harming yourself? Yes/No
Have you felt excessively guilty or worthless? Yes/No
Has your concentration been poor? Yes/No
30. Are you currently being treated for depression? If yes, please give details.
31. Are you currently suffering from emotional or mental health problems (if not mentioned 
above)?
Yes/No
Please provide some details
32. Have you suffered from emotional or mental health problems in the past?
33. When did your current sleeping difficulties occur in relation to these mental health 
difficulties?
34. Please provide details of any medication that you are currently taking (or have been taking 
in the past three months) for sleep difficulties or any other purpose.
35. Are you currently receiving psychological help for sleeping difficulties?
Yes/no
36. Do you drink alcohol? Yes/No 
If yes, what do you usually drink?
How many of these alcohol drinks do you usually have per day (if not daily, how many in a 
week)?
Do you feel that your alcohol use disrupts your sleep?
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37. Do you use illicit drugs? Yes/No 
If yes, what do you usually use?
How much do you have in a day (if not daily, in a week)?
Do you feel that your drug use disrupts your sleep?
38. Do you find that you fall asleep at the ‘wrong’ time?
□ Never □ Sometimes □ Usually □ Always
39. In what way do you feel that it is wrong?
40. Do you have difficulties waking up at a set time in the morning (or would you if you are
currently not required to) in order for example to be ready to leave for work at for 8.15 am?
Yes/No
If yes, in what way (e.g. keep falling asleep again, feel you need to sleep more due to a 
bad night)?
41. If you had no social constraints (e.g. work) is there particular times that would optimise
your chances of having a good sleep? Yes/No
If yes, what would these be?
Sleep a t  Get up at...........
42. Do you snore during your sleep?
□ Never □ Sometimes □ Usually □ Always
43. If you do, how do you know? For example, has your partner been awoken?
44. Do you hold your breath, have breathing pauses or stop breathing in your sleep?
□ Never □ Sometimes □ Usually □ Always
If you do, how do you know? For example, has your partner noticed this?
45. Do you think breathing difficulties may be the main cause of your sleeping problem? Why 
do you think this is the case?
46. Do you fall asleep unintentionally or have to fight to stay awake during the day?
□ Never □ Sometimes □ Usually □ Always
47. When you wake up in the morning do you feel unrefreshed and groggy?
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□ Never □ Sometimes □ Usually □ Always
48. Please indicate how likely you are to fall asleep in the following situations. Use the scale 
below to indicate how likely you are to fall asleep in each situation:
0 = would never dose
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing
Situation Record chance of dozing 0,1,2,3
Sitting and reading ______________
Watching TV ______________
Sitting, inactive in a public place ______________
(e.g. a theatre or a meeting)
As a passenger in a car for an hour without a break ______________
Lying down in the afternoon to rest when
circumstances permit ______________
Sitting and talking to someone ______________
Sitting quietly after lunch without alcohol ______________
In a car, while stopped for a few minutes in the
traffic ______________
49. Do you experience repeated, uncontrollable leg jerks or leg twitches during your sleep? 
□ Never □ Sometimes □ Usually □ Always
50. Do you think such uncontrolled limb movements may be the main cause of your sleeping 
problem?
51. Do you experience restless or “crawling” feelings in your legs at night which go away if you 
move your legs?
□ Never □ Sometimes □ Usually □ Always
52. Do you think such restless legs may be the main cause of your sleeping problem?
53. Do you experience excessive sleepiness and sudden muscle weakness?
54. Do you experience any of the following:
- nightmares
- inability to perform voluntarily movements before going to sleep, or upon wakening
- grinding/clenching teeth
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- sleepwalking/talking
- night terrors (waking up screaming or with an intense feeling of terror)
How often?
55. Do you feel that you have any other difficulties related to sleeping that have not been 
covered in this interview?
56. Are you physically well at present?
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Appendix 4.3
UNIVERSITY
GLASGOW
Investigating Bedtime Thoughts of People Who Have Difficulty 
Falling Asleep
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if 
there is anything that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part.
Thank you for reading this.
What is the purpose of the study?
Most individuals who experience difficulties falling asleep complain that the their mind is dominated 
by unwanted thoughts and worries while trying to get to sleep which they think is barrier to them 
falling asleep. It is possible that ‘unfinished’ business from the day intrudes during the pre sleep 
period and interferes with the process of falling asleep.
Some research has found that asking participants to write about their innermost thoughts and 
emotions regarding traumatic or significantly emotional events has resulted in health and 
psychological improvements. Although there a few theories as to why this works, no one knows for 
certain.
This study aims to investigate whether asking people who experience difficulties falling asleep to 
write about their worries will reduce the time it takes them to fall asleep and reduce the amount of 
unwanted thoughts and worries they experience while trying to fall asleep.
Why have I been chosen?
You are one of 28 people who have been asked to take part in this study because you experience 
difficulty falling asleep.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you will be given 
this information sheet to keep and be asked to sign a consent form (which you will also be given a 
copy of to complete). If you decide to take part you are still free to withdraw at any time and without 
giving a reason.
What will happen to me if I take part?
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You will be asked to take part for four days, although the research study will last for approximately 
8 months. You will need to visit Gartnaval Royal Hospital twice for about one hour each time. The 
first time you visit, the researcher will ask you some questions about your sleep and your mental 
health and will be asked to complete some questionnaires. You will also be given an envelope with 
instructions in it telling you exactly what you should do for the next four nights and a special ‘watch’ 
which will automatically measure when you fall asleep and when you wake up.
Sometimes because we do not know which way of dealing with problems is best, we need to make 
comparisons. People will be put into two groups and then compared. The groups are selected by 
a computer which has no information about the individual -  i.e. selection is by chance. People in 
each group have to do something different and then their results are compared. You have a 50/50 
chance of being in either group.
What do I have to do?
Everyone will be asked to wear the special ‘watch’ at all times during the study (except when 
bathing) and to complete a questionnaire and a diary recording details regarding their sleep (e.g. 
when you got to sleep) in the morning. This should take approximately 10 minutes. Everyone 
should do this and go to sleep as usual on the first night. On the next three nights, you will be 
asked to either write about your worries for approximately 20 minutes per evening (which you will 
not need to show to anyone) or you will be asked to fill in some questionnaires about your worries 
(which will also take about 20 minutes per evening). You will be asked not to drink alcohol for the 
four nights while taking part. You can continue to take any usual prescription medications etc.
What are the alternatives for diagnosis or treatment?
If you do not wish to take part, you may still contact your doctor for advice regarding your sleeping 
difficulties.
What are the side effects of taking part?
There are no side effects of taking part, although you should not expect any improvement in sleep 
by doing so.
What are the possible disadvantages and risks of taking part?
There are also no disadvantages, except that it will take time out of your day to complete the 
questionnaires etc with no benefit to your sleep. There are no risks to you from taking part in this 
study.
What are the possible benefits of taking part?
There is no direct benefit to you from taking part in this study. The information we get from this 
study may help us to understand more about sleep difficulties and treat future patients with 
problems falling asleep better.
What if new information becomes available?
Sometimes during the course of a research project, new information becomes available. If this 
happens, the researcher will tell you about it and discuss with you whether you want to continue in 
the study. If you did decide to continue in the study you will be asked to sign an updated consent 
form. Also, on receiving information your researcher might consider it to be in your best interests to 
withdraw you from the study and he/she will explain the reasons.
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What happens when the research study stops?
When the research study stops, you will be given an information leaflet which contains advice on 
things that you can do to possibly help you sleep better.
What if something goes wrong?
If you are harmed by taking part in this research project, there are no special compensation 
arrangements. If you are harmed due to someone’s negligence, then you may have grounds for a 
legal action but you may have to pay for it. Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated during the course of 
this study, the normal National Health Service complaints mechanisms should be available to you.
Will my taking part in this study be kept confidential?
All information which is collected about you during the course of the research will be kept strictly 
confidential. Any information about you will have your name and address removed so that you 
cannot be recognised from it. Your GP will not be notified of your participation and no one from the 
study will have access to your medical records.
What will happen to the results of the research study?
The results of the research will be published in an academic journal in approximately one year’s 
time. You will not be identified in any report/publication. You can obtain a copy of the published 
results from the address below.
Who is organising and funding the research?
This research is organised by Patricia Mooney, Trainee Clinical Psychologist (see contact details 
below) and sponsored by Greater Glasgow Primary Care NHS Research and Development 
Department.
Who has reviewed the study?
This study has been reviewed by Greater Glasgow Primary Care Research Ethics Committee.
Contact for Further Information
If you should require further information, please contact:
Patricia Mooney
University of Glasgow
Department of Psychological medicine
Gartnavel Royal Hospital
1055 Great Western Road
Glasgow
G12 0XH
Email: 0309254m@student.qla.ac.uk 
Telephone: 0141 211 0607
Thank you for taking part in this study!
Version 2 25/7/05
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UNIVERSITY
$
GLASGOW
Patient Identification Number for this trial:
CONSENT FORM
Investigating Bedtime Thoughts of People Who Have Difficulty 
Falling Asleep
Researcher: Patricia Mooney
Please initial box
1. I confirm that I have read and understand the information sheet dated 25/07/05.
(version 2) for the above study and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected.
3. I agree to take part in the above study.
□
□
□
Name of Patient Date Signature
Name of Person taking consent Date Signature
(if different from researcher)
Researcher Date Signature
1 for patient; 1 for researcher
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Appendix 4.5
Writing Task Instructions
“For the next 3 days, in the early evening (between 6pm and 8pm), I  would like you to 
spend 20 minutes writing about any thoughts, concerns, worries, or things on your mind. 
In your writing, I ’d like you to be really honest, so that you can explore your very deepest 
thoughts and emotions. You are not going to be asked to show anyone what you write. 
Take the opportunity to explore your deepest thoughts and feelings about something that is 
emotionally important to you and is bothering you at the moment. Please write in as much 
detail as you can and explore every aspect o f the topics you are writing about. You can 
write about the same issue every evening, or you may decide to cover several topics over 
the 3 sessions. ”
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Appendix 4.6
Participant Number
' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k r ^ / ^ v v ^ r ^ l i nComplete in morning*
Alertness Scale
Please rate how mentally alert you fe lt last night while you were trying to get 
to sleep by circling one number on the scale.
1 2 3 4 5
Not at all Slightly Moderately A lot Extremely
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Appendix 4.7
Participant N u m b e r ____________________
^  a #  %A* ^  T v ®  ® 4 *  *1^ »jv vjv \ l v  vjv s l v  \ | v  \1» v{/^ ^ yyipiQiO' in morning
Writing Task Questionnaire
Please think about your writing t o *  wg//Z when answ ering the next 3 
questions and circle the most appropriate response.
I worked through some upsetting issues:
Very m uch To some extent Not at all
Writing helped me organise my thoughts:
Very much To some extent Not at all
My thoughts/opinions have changed regarding the subject I wrote about:
Very m uch To some extent Not at all
